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ABSTRACT 
Weight Status, Leptin, and Cognitive Function in Anorexia Nervosa 
Staci A. Berkowitz 
 
 
Objective: Anorexia nervosa (AN) is a debilitating illness and is highly resistant to 
treatment.  Prior research in AN has emphasized the importance of low absolute body 
weight, but emerging research suggests the importance of also considering low body 
weight relative to an individual’s highest past weight (weight suppression; WS).  Leptin 
is a hormone produced by adipose tissue that increases in proportion to body fat.  Prior 
research has identified a relationship between BMI and leptin, while the potential 
relationship with WS is less well established.  Research also suggests that individuals 
with AN display cognitive impairments on a range of neuropsychological tests.  The 
interpretation of such impairments is complicated by the potential for starvation and low 
body weight to influence performance.  Additionally, there is reason to suspect that 
weight status variables (BMI, WS) and/or leptin may be related to cognitive performance. 
Therefore the goals of the present study are: (1) to evaluate the relationship between 
weight status variables and leptin; (2) to evaluate the relationship between weight status 
variables and cognitive performance; (3) to evaluate the relationship between leptin and 
cognitive performance.  These relationships were evaluated twice, once when patients 
were first admitted and again after they gained weight to reach 90% of their ideal body 
weight.   Participants: Data were collected from 64 women with AN at an inpatient 
eating disorder treatment facility; a subsample of 33 of these women also provided blood 
samples for leptin assay.  Methods: Data were collected at two time points: at admission 
and soon after weight restoration.  At each time point, participants completed a series of 
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neuropsychological tests (including measures of memory, cognitive flexibility and spatial 
reasoning), blood was collected for leptin assay, and weight status variables (including 
BMI and WS) were calculated.  Results: (1) At admission, both weight status variables 
were associated with leptin; higher WS and lower BMI were independently associated 
with lower leptin level. Following weight restoration, the WS/leptin relation held whereas 
the BMI/leptin relation did not.  (2) At admission and following weight restoration, 
weight status variables were mostly unrelated to performance on cognitive tasks, with the 
exception of performance on one memory task. (3) At admission and following weight 
restoration, leptin was mostly unrelated to performance on cognitive tasks, although a 
non-significant association with spatial reasoning task performance emerged. 
Conclusions: Leptin appears to be a marker not only of current body fat levels but also of 
the discrepancy between past highest weight and current weight.  These findings suggest 
that the body may be defending against weight loss from a previous highest level, not just 
from a medically healthy body mass. Thus, weight gain to a minimally healthy level may 
not be sufficient to restore leptin to normal levels.  Findings also suggest that weight 
status and leptin do not have a robust influence on the specific cognitive tasks considered 
in the current study.  Notably, cognitive task performance was not impaired among AN 
individuals in the current study as compared to data from a normative sample, potentially 
influencing this finding.  Future studies should evaluate whether other domains of 
cognitive performance are related to weight status and/or leptin to continue to clarify 
whether neurocognitive abnormalities identified in AN are weight-related and/or more 
integral to the specific psychopathology associated with the disorder. 
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CHAPTER 1: INTRODUCTION 
 Anorexia nervosa (AN) is a debilitating illness and is highly resistant to treatment.  
Individuals with this disorder display cognitive impairments on a range of 
neuropsychological tests; however, the interpretation of such impairments is complicated 
by the potential for starvation and low body weight to influence performance.  This study 
evaluates the potential for weight status to be related to cognitive performance and for 
leptin, a hormone produced by adipose tissue, to help explain any relationship between 
these variables.  In the following section, the diagnosis of AN is explored followed by a 
discussion of the significance of weight status, leptin, and cognitive function in AN.  
Finally, the specific research aims tested are presented. 
1.1 Anorexia Nervosa 
 Anorexia nervosa (AN) is a serious psychiatric illness affecting one percent of the 
population (Hudson, Hiripi, Pope, & Kessler, 2007).  The disorder is characterized by a 
severe disturbance in the way body shape and weight are experienced and maintenance of 
a low body weight relative to that expected based on age and height. Anorexia nervosa 
has the highest mortality rate of any psychiatric disorder, with an estimated 5-6% 
mortality rate per decade of illness (Arcelus, Mitchell, Wales, & Nielsen, 2011; Sullivan, 
1995).  
 Anorexia nervosa is one of three eating disorder diagnostic categories included in 
the Diagnostic and Statistical Manual for Mental Disorders – Fourth Edition (DSM-IV; 
1994), along with bulimia nervosa (BN) and eating disorder not otherwise specified 
(EDNOS).  While the specific diagnostic criteria differ among the three categories, they 
are thought to share a common psychopathology – namely an overevaluation of shape, 
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weight, and their control – that is distinctive to eating disorder diagnoses (Fairburn, 
2008).   
 Two diagnostic subtypes of AN are described by the DSM-IV, including the 
restricting (R) and binge-eating/purging (BP) subtypes.  Individuals with AN-R solely 
restrict their caloric intake of food while individuals with AN-BP additionally report 
engaging in binge eating and/or purging behavior.  Binge eating refers to a discrete eating 
episode during which an individual consumes an amount of food that is objectively large 
and experiences a sense of loss of control.  Purging, on the other hand, refers to a group 
of behaviors intended to rid the body of calories, including self-induced vomiting or 
misuse of laxatives or diuretics.  While binge eating and purging behaviors are also 
characteristic features of BN, the weight criterion differentiates the two diagnoses – an 
individual at low body weight would necessarily be considered for an AN-BP rather than 
BN diagnosis.    
 The weight criterion in the DSM-IV, specifically “refusal to maintain body weight 
at or above that expected,” is a core feature of AN, however the exact threshold for low 
body weight is somewhat arbitrary.  The DSM-IV provides the example that body weight 
at or below 85% of that expected based on age and height meets the weight criterion for 
diagnosis; while this value was intended as a guideline, the 85% mark is often used 
clinically as a cut-off point for diagnosis.  In the new version of the DSM, DSM-5 
(2013), the weight criterion has been clarified to remove mention of a specific percentage 
and notes that weight should be evaluated in the context of age, sex, developmental 
trajectory, and physical health.  
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 Furthermore, the amenorrhea criterion used in DSM-IV has been removed in 
DSM-5.  According to DSM-IV, post-menarchal women must be amenorrheic, or 
experience a cessation of menses for at least three consecutive cycles, to meet full criteria 
for the disorder.  Research suggests that while many post-menarchal women stop 
menstruating due to weight loss associated with AN, others continue menstruating despite 
similar symptoms and severity level (Attia & Roberto, 2009).  Because the criterion does 
not seem to meaningfully distinguish between individuals with AN symptoms, the 
amenorrhea criterion has been removed in DSM-5.   
 Along with amenorrhea, many medical consequences are associated with the 
weight loss and malnutrition seen in AN (Cooke et al., 1994; Lawson & Klibanski, 2008; 
Mitchell & Crow, 2006; Sharp & Freeman, 1993). Bone mineral density is affected in 
individuals with AN, with high rates of osteopenia and/or osteoperosis observed in 
adolescent and adult samples (Castro, Lazaro, Pons, Halperin, & Toro, 2000; Steven 
Grinspoon et al., 2000).  Furthermore, individuals with AN often enter a hypometabolic 
state in which the body makes an effort to conserve resources.  In particular, slowed heart 
rate (bradycardia), decreased blood pressure (hypotension), and decreased body 
temperature (hypothermia) are common medical complications (Attia, 2010).  
Additionally, electrolyte abnormalities are particularly common in individuals who 
engage in purging behavior, further contributing to cardiac problems, such as arrhythmias 
(Attia, 2010).  
 The medical complications of AN extend to the endocrine system as well, with 
abnormalities seen across sex, stress, and appetitive hormones.   Sex hormones, including 
both estrogen and testosterone, are decreased in individuals presenting with AN.   At low 
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body weights, hypothalamic gonadotripin-relesasing-hormone (GnRH) is suppressed, 
ultimately decreasing ovarian output of estrogen associated with menstrual activity 
(Lawson & Klibanski, 2008; Sharp & Freeman, 1993).  Both estrogen and testosterone 
may influence bone mineral density (Lawson & Klibanski, 2008), and testosterone is also 
associated with decreased libido (Davis & Tran, 2001).  Additionally, increases in 
cortisol levels are observed in this patient population.  Abnormalities in anorexigenic and 
orexigenic hormones, associated with decreased and increased appetite respectively, are 
also seen in AN.  These shifts are thought to be triggered by decreases in the hormone 
leptin (Lawson & Klibanski, 2008), and are discussed in greater detail in later sections of 
this paper.   
 Anorexia nervosa is not a new disorder; reports of self-starvation date back to the 
Hellenistic era, during the 4th century A.D., and medical descriptions of similar 
symptoms were provided as early as the 17th century by Richard Morton (Pearce, 2004).  
While sociocultural pressures to obtain a thin body weight may influence prevalence, 
reports of AN extend to non-Western cultures that have not placed value on “thin ideal” 
body types (Pamela K Keel & Klump, 2003).   
 Anorexia nervosa most commonly onsets during adolescence and is diagnosed ten 
times more frequently in females than in males (Hoek & Van Hoeken, 2003).  Recovery 
rates for AN are disheartening; a meta-analysis including 119 AN outcome studies 
suggests that over long-term follow-up only 47% of individuals fully recovered, 34% 
achieved partial remission, and 21% of patients remained chronically ill (Steinhausen, 
2002). Anorexia nervosa is notoriously difficult to treat and no singular treatment has 
gained empirical support as the best option for adults with AN (Attia, 2010).   
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1.2 The Role of Weight Status 
 Weight suppression (WS) has gained recent attention in the eating disorders field 
as a variable of interest, with findings over the last decade showing its implication in an 
increasing number of eating disorder outcomes.  Weight suppression is the difference 
between an individual’s previous highest adult body weight and current body weight.  
Weight suppression provides a measure of relative weight status, that is, the amount of 
weight an individual has lost relative to their own previous highest weight.  Weight 
suppression is contrasted with absolute body weight variables that provide an index of 
where an individual’s weight falls in comparison to the general population.  Body mass 
index (BMI), calculated as body mass per squared unit of height (kg/m2), is often used as 
an index of absolute body weight, allowing for assessment of weight status in the context 
of population standards.  According to the National Institutes of Health (1998), a “normal 
weight” BMI fall between 18.5 and 24.9 kg/m2, with a mean value of 21.75 kg/m2 that 
can be used as a rough approximation of healthy weight for height.  Individuals with a 
BMI below 18.5 kg/m2 are classified as “underweight,” while individuals with a BMI 
above 24.9 kg/m2 may be classified as “overweight” or “obese.”  
 An individual’s body weight at any moment in time may be described in both 
absolute and relative terms.  Likewise, the effect that a particular weight loss has on an 
individual may be influenced by both relative and absolute weight variables (Berner, 
Shaw, Witt, & Lowe, 2013).  For example, the impact of a weight loss of 25 pounds may 
differ for an individual who was previously overweight and an individual who was 
previously at a healthy body weight.  While both individuals may experience a biological 
drive to return to their previous highest weight (MacLean, Bergouignan, Cornier, & 
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Jackman, 2011; Rosenbaum & Leibel, 2010), the latter individual may become 
underweight and also be more likely to experience more intensive or widespread 
psychobiological starvation responses.  Additionally, weight loss to the same low body 
weight, in absolute terms, may differentially affect individuals, depending on the amount 
of weight lost (and, relatedly, the individual’s previous highest weight).  It seems the 
body may be “invested” in both relative shifts in body weight (i.e., WS) and the resulting 
absolute weight (e.g., BMI or classifications of “overweight, ”“normal weight,” and 
“underweight”).  For the purposes of this study, the term “weight status” is used as an 
inclusive term to refer to both measures of relative (WS) and absolute (BMI) body 
weight.  
1.3 Evidence for the Influence of Weight Suppression 
 Weight suppression has been identified as a relevant variable in the prediction of 
weight outcomes among healthy individuals.  Lowe et al. (2006) examined the ability for 
WS to predict weight gain in female college freshman.  Higher WS predicted greater 
weight gain over the course of one year, when BMI at study entry was controlled.  Stice 
et al. (2011) replicated these findings and additionally tested whether the physiologic 
variables resting metabolic rate (RMR) and total energy expenditure (TEE) were 
implicated.  It was demonstrated that WS was inversely correlated with resting metabolic 
rate (RMR) and total energy expenditure (TEE); however, RMR and TEE did not mediate 
the relationship between WS and weight gain.  It seems that WS predicted greater weight 
gain and decreased RMR and TEE in healthy women but that these variables did not 
account for the prediction of weight gain by WS.   This suggests that highly weight 
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suppressed individuals are eating more than their TEE or that their body is converting a 
higher percentage of ingested calories into body mass.   
 Weight suppression has also been studied in individuals with eating disorders, and 
was initially considered as a variable of interest in BN, predicting both short- and long-
term outcomes for these individuals.  While individuals with BN are usually in a normal 
weight range according to absolute standards, these individuals tend have elevated levels 
of WS compared to healthy individuals (Butryn, Lowe, Safer, & Agras, 2006;  Lowe, 
Davis, Lucks, Annunziato, & Butryn, 2006).  Higher WS at the outset of treatment has 
been associated with greater weight gain over the course of treatment for BN, in both 
outpatient and residential settings (even though weight change is not typically an explicit 
treatment target for these individuals (Carter, McIntosh, Joyce, & Bulik, 2008;  Lowe et 
al., 2006).  Weight suppression has also predicted weight gain among treatment-seeking 
individuals with BN over a 5-year follow-up period, with individuals with higher levels 
of WS gaining more weight over time ( Herzog et al., 2010).  
 Taken together, the findings from healthy individuals and BN samples suggest 
that WS is associated with a subsequent weight gain.  This is consistent with the notion 
that the body has biological drives that promote weight gain toward its highest previous 
level.  It seems weight loss may promote both increased metabolic efficiency and/or 
increased food consumption, leading to weight gain among weight-suppressed 
individuals.   
 In addition to the influence of WS on weight change, WS has also predicted BN 
symptom severity.  Specifically, higher levels of WS have been associated with greater 
binge eating and purging frequency (Butryn, Juarascio, & Lowe, 2011;  Lowe, Thomas, 
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Safer, & Butryn, 2007).  Weight suppression has also been associated with BN treatment 
outcome, with individuals at higher levels of WS prior to treatment demonstrating a 
greater likelihood of dropping out of treatment and increased likelihood of continued 
binge eating and purging post-treatment ( Butryn et al., 2006); however, further studies 
have not been able to replicate these treatment outcome findings (Frances A Carter et al., 
2008; Zunker et al., 2011).  
 Given that WS has predicted several outcomes for individuals with BN, an 
important theoretical consideration is whether WS causally influences outcome, or 
whether WS is merely a proxy of another causal variable.  Many hypothetical alternative 
relationships have been tested to discount a range of other possible explanations.  For 
instance, it is hypothetically possible that WS is a proxy of eating restraint and that eating 
restraint explains the predictive relationship between WS and binge eating and purging 
(Butryn et al., 2006).  However, studies have controlled for potentially confounding 
eating disorder psychopathology variables –  such as eating restraint, shape concerns, and 
weight concerns – and have found that WS predicts binge eating and purging even when 
such variables are controlled (Butryn et al., 2011;  Butryn et al., 2006;  Lowe et al., 
2007).  Additionally, variables such as age or duration of illness could hypothetically be 
implicated as individuals who are older, or who have been ill for longer, may have more 
time to reach a higher weight and then lose a greater amount of weight.  Several studies, 
however, have controlled for such variables and have found that WS continues to predict 
BN symptomatology and weight gain (Butryn et al., 2011;  Butryn et al., 2006;  Herzog et 
al., 2010;  Lowe et al., 2011).  Furthermore, it is important to consider whether the 
specific construct captured by WS is predictive of outcomes, or if WS is simply a proxy 
/!!!
for other weight variables.  Several studies have considered previous highest weight as a 
potential confound, as proneness towards overweight could account for the predictive 
relationship.  Increasing evidence suggests that WS predicts outcome even when other 
weight variables – such as past highest weight or the difference between current and 
lowest weight – are controlled (Butryn et al., 2006;  Lowe et al., 2011;  Lowe et al., 
2006).  Taken together, the findings suggest that there is a unique predictive value to WS, 
and that WS does not seem to be simply a proxy for other measures.  (For a review of 
studies looking at WS in BN, see Appendix Table A1.)   
1.4 Weight Status in Anorexia Nervosa 
 Individuals with AN are by definition at low body weights according to absolute 
standards, and they are also at low body weights relative to their previous body size.    
While all individuals with AN present with low body weights, there is great variability in 
their previous highest weight (Coners, Remschmidt, & Hebebrand, 1999; Miyasaka et al., 
2003), and thus great variability in level of WS. 
 As individuals with AN are extremely malnourished when they present for 
treatment, the initial goals of treatment include medical stabilization and weight 
restoration. Because of the high level of resistance to weight gain that characterizes the 
disorder, weight restoration guidelines become a critical component of care for these 
individuals.   
 Many eating disorder treatment facilities set target weights for patients based on 
patient height, directing patients towards minimally acceptable absolute body weights.   
Interestingly, many treatment facilities do not consider the specific weight history of 
individual patients.  For example, if two patients of the same height were hospitalized for 
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treatment of AN, one with previous lifetime highest weight of 150 pounds and the other 
with a previous lifetime highest weight of 120 pounds, the target weight goal for these 
two individuals may be identical. Although traditionally emphasis has been placed on the 
role of absolute low body weight in AN, emerging findings suggest that WS may also 
have important clinical implications for these patients, above and beyond BMI  
(Berkowitz et al., 2011, April; Berkowitz et al., 2012, November; Berner et al., 2013; 
Klein et al., 2011, July; Wildes & Marcus, 2012; Witt et al., 2014).  
  Weight suppression at admission to treatment for AN has been associated with 
longitudinal weight outcomes.  Although weight gain is an inherent component of 
treatment for all AN individuals, individuals with higher as compared to lower WS 
gained weight more rapidly and gained more weight overall during intensive treatment 
for AN, controlling for initial BMI (Wildes & Marcus, 2012).  These findings are 
supported by findings from a residential treatment facility which also demonstrate the 
predictive significance of WS on weight change (Berner et al., 2013).  
 Furthermore, WS has been associated with symptom severity in AN patients. 
Cross-sectional data demonstrated that patients higher in WS reported more severe eating 
disorder and depressive symptoms at admission to a residential treatment facility (Berner 
et al., 2013).  Additionally, higher levels of WS have been associated with increased 
likelihood of binge eating and/or purging during the last four weeks of intensive 
treatment for AN, controlling for BMI (Wildes & Marcus, 2012).   
 Taken together, the findings indicate that WS may be a relevant predictor of 
weight gain and psychological symptoms in AN.  These findings suggest that WS 
provides valuable information above and beyond BMI.  Berner and colleagues (2013), 
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however, explained that the biological and psychological significance of WS may depend 
on the severity of low BMI, and similarly, the significance of a low BMI may depend on 
the severity of WS; thus, it may be important to consider the conjoint influence of these 
two weight variables.  
 Two recent studies have evaluated the potential for WS and BMI to serve as 
conjoint predictors of outcome (Berner et al., 2013; Witt et al., 2014).  In a sample of AN 
patients at a residential treatment facility, Berner and colleagues identified that the 
interaction between WS and BMI at admission predicted psychological symptoms at 
discharge. They found that among those with lower admission BMIs, higher WS 
predicted lower symptomatology at discharge, while among those with higher admission 
BMIs, higher WS predicted greater symptomatology at discharge.  Berner and colleagues 
also reported an interaction between these two weight variables on weight gain during 
treatment.  Specifically, the greatest weight gain was found among individuals with lower 
admission BMIs and higher WS. Witt and colleagues (2014) extended the consideration 
of these two weight variables to the long term, evaluating their predictive significance in 
a longitudinal study of adolescents with AN identified through community screening.  
They identified an interaction between WS and BMI (measured during the first episode 
of AN) on weight outcome as of both 6- and 10-year follow-up, suggesting the predictive 
utility of these variables on long-term absolute weight status.  The interaction pattern 
identified in this study was consistent with the interaction pattern identified by Berner et 
al. on short-term weight outcome.  Thus, preliminary evidence suggests that WS and BMI 
during acute AN may conjointly predict outcomes in the short and long term. 
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 The aforementioned studies considered the implications of WS during the acute 
state of AN, however WS following treatment is also potentially relevant.  Following 
weight restoration, patients are by definition less weight suppressed than they were 
previously; however, great variability likely remains in the extent to which an individual 
is below her previous highest weight.  Loss of menstrual function is commonly associated 
with the diagnosis of AN, and restoration of menstrual function is an important indicator 
of restored physical health for women with this illness.  Two studies have looked at the 
restoration of menstrual function during hospitalization for AN at an inpatient facility that 
discharges patients four to six weeks following initial weight restoration (Berkowitz et 
al., 2011, April; Klein et al., 2011, July).  While all patients evaluated were amenorrheic 
at admission, those who were less weight suppressed at discharge were more likely to 
have recovered menstruation than those with higher levels of WS, independent of 
absolute BMI (Berkowitz et al., 2011, April).  This further suggests that the body is 
invested in not only being at a healthy weight for height but also at a weight closer to 
one’s highest past weight. (For a review of studies looking at WS in AN, see Appendix 
Table A2.)   
1.5 Leptin 
 Leptin is a protein hormone produced by adipose tissue that helps regulate energy 
intake and energy expenditure.  Higher leptin levels are associated with greater amounts 
of body fat, attributed to the production of the hormone by fat cells themselves (Ostlund, 
Yang, Klein, & Gingerich, 1996).  Leptin is thought to function as a messenger to the 
brain on the amount of energy stores available to the body, with greater levels signaling a 
reduction in appetite and an increase in energy expenditure (Stoving et al., 2009).  Leptin 
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is influenced by both short-term shifts in energy availability (e.g., changes in food intake 
over a 24-hour period) as well as longer-term states reflective of fat store availability.  
Therefore, changes in leptin may be in response to either changes in energy intake and/or 
changes in body fat stores, with an enduring reduction in leptin seen in response to long-
term reduction in body weight.  Leptin specifically acts within the hypothalamus to 
stimulate the release of anorexigenic peptides (e.g., proopriomelanocotin) and suppress 
the release of orexigenic peptides (e.g., agouti-related protein; neuropeptide Y (Kelesidis, 
Kelesidis, Chou, & Mantzoros, 2010).  Leptin is additionally thought to trigger increases 
in thyroid hormones, thereby increasing metabolic rate (Chan, Heist, DePaoli, Veldhuis, 
& Mantzoros, 2003).  Thus, leptin contributes to the maintenance of energy and weight 
homeostasis, with an especially strong role in alerting the brain to an ongoing state of 
starvation (Kelesidis et al., 2010; Prentice, Moore, Collinson, & O'Connell, 2002).  
Leptin seems to change more drastically in response to an energy deficit than to an 
energy surplus (Chin-Chance, Polonsky, & Schoeller, 2000).  During chronic starvation 
the decrease in leptin is thought to initiate further neuroendocrine shifts within the body, 
not only influencing appetitive and metabolic signals, but also influencing reproductive 
function (Chan et al., 2003; Kelesidis et al., 2010).  
1.6 Leptin in Anorexia Nervosa 
Individuals with AN reach dangerously low body weights, having reduced their 
energy intake to the point of starvation.  Consistent with the link between leptin and 
starvation, individuals with acute AN present with extremely low leptin levels 
(Grinspoon et al., 1996).  Leptin levels among AN individuals are routinely lower than 
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age-matched healthy controls or healthy, lean individuals (Föcker et al., 2011; Hebebrand 
et al., 1997). 
Weight restoration during treatment for AN, involving both a normalization of 
energy intake and a resulting weight gain, has been associated with an increase in leptin 
(Hebebrand et al., 1997).  Presumably increases in energy and fat store availability lead 
to an increase in leptin production during weight gain.  While a positive association 
between leptin level and BMI has been well documented in eating disorder individuals 
and the general population (Ferron et al., 1997; Ruhl et al., 2004), limited data is 
available on the potential association between WS and leptin. 
A pilot study, which included a subsample of inpatients with AN included in the 
current study, assessed the relationship between WS and leptin (Klein et al., 2011, July).  
All patients had recently restored their weight to a minimally acceptable body weight (at 
least 90% of that expected based on height) during treatment.  While patients reached 
healthy weights in absolute terms (i.e., they were no longer “underweight”), there was a 
great range in WS – from zero to over 90 pounds – at discharge.  Klein and colleagues 
(2011, July) noted a negative association between leptin level and WS at discharge, 
suggesting that on average AN patients with higher leptin levels at discharge were closer 
to their previous highest weights.  Although both BMI and WS seem to be highly related 
to leptin level, the potential for these two weight variables to conjointly predict leptin 
level has not heretofore been studied. 
Though more evidence is needed, leptin may serve as a useful biomarker for 
weight status and physiological functioning in AN.  In addition to the independent 
relations identified between leptin and both BMI and WS, leptin may correspond most 
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closely with measures of percent body fat (Blum et al., 2003; Ruhl et al., 2004). Reliable 
measures of body fat percent are measured through dual-energy X-ray absorptiometry 
(DXA), which involves a much more time-consuming and costly procedure than 
measurement of serum leptin.  Furthermore, while percent body fat accounts for much of 
the variability in leptin, 30 to 50% of the variability still remains unexplained (Blum et 
al., 2003; Ruhl et al., 2004).   
Leptin may also be a variable of interest because of its presumed role as a 
messenger to both central and peripheral systems.  Although fat stores directly influence 
leptin, it seems to be leptin, rather than fat stores themselves, that lead to resulting 
physiologic changes.  In fact, leptin significantly decreases in response to 52- to 72-hour 
fasting, changing more drastically than body fat stores (Boden, Chen, Mozzoli, & Ryan, 
1996; Weigle et al., 1997), and administration of leptin to fasted individuals reverses 
metabolic consequences (Chan et al., 2003). 
1.7 Cognitive Function in Anorexia Nervosa 
 The behavior exhibited by individuals with AN is often extremely ritualized and 
repetitive.  Individuals with this disorder, for example, may eat the same foods at the 
same time each day, counting the calories of their foods at each meal.  These individuals 
are commonly described as perfectionistic and obsessional, focusing in on unobtainable 
standards, including an unrealistic and unhealthy “thin ideal,” (Kidd & Steinglass, 2012).  
The observation of such behavioral and psychological characteristics have led to growing 
interest in the potential role for cognitive deficits to be implicated in the onset and/or 
maintenance of the disorder.   
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 Impairments in cognitive functioning have been identified in individuals with AN.  
These deficits range from deficits in cognitive flexibility (Giovanni et al.; Sarrar et al., 
2011;  Steinglass, Walsh, & Stern, 2006; Tchanturia et al., 2004), reward processing 
(Steinglass et al., 2012), processing speed (Sarrar et al., 2011), memory (Bayless et al., 
2002; Green, Elliman, Wakeling, & Rogers, 1996; Mathias & Kent, 1998; Moser et al., 
2003; Nikendei et al., 2011), and attention (Kingston, Szmukler, Andrewes, Tress, & 
Desmond, 1996). Studies suggest that some cognitive deficits may improve with weight 
restoration, while others appear to change little (Green et al., 1996; Kingston et al., 1996; 
Lauer, Gorzewski, Gerlinghoff, Backmund, & Zihl, 1999; Sarrar et al., 2011;  Tchanturia 
et al., 2004).   
 The reason that some cognitive deficits improve with weight restoration while 
others do not is not entirely understood. Deficits that improve following weight 
restoration may be impacted, at least in part, by the state of starvation and malnutrition 
associated with the disorder (Kingston et al., 1996; Lauer et al., 1999).  Whether relative 
and/or absolute weight status, in particular, contribute to cognitive performance is 
unclear.  Deficits that do not improve following weight restoration, on the other hand, 
may theoretically remain deficient for several reasons.  First, it is possible that the 
individual did not regain enough weight (in relative and/or absolute terms) or did not 
maintain their new weight for a long enough period of time, such that their body is still 
responding to a low weight status.  Second, it is possible that the deficit is not secondary 
to weight status, but rather was present prior to the illness or is integral to the specific 
pathology seen in AN (Lena, Fiocco, & Leyenaar, 2004).  Third, the onset of AN for 
many individuals occurs during adolescence when the brain is still undergoing 
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development.  The experience of chronic starvation during critical developmental periods 
may affect long-term brain functioning, perhaps leading to cognitive deficits that do not 
reverse even after the disorder has remitted (Hatch et al., 2010).  
1.7.1 Cognitive Flexibility 
 Cognitive flexibility is a domain that has gained particular interest in the field of 
eating disorders.  Cognitive flexibility is a higher-order function referring to the ability to 
adapt to changing environmental cues (Kidd & Steinglass, 2012). Deficits in cognitive 
flexibility are thought to be associated with rigid approaches to problem solving and 
difficulties with dynamic interpersonal interactions (Pender, 2011).  Cognitive flexibility 
is often measured using set-shifting tasks, which assess an individual’s ability to 
promptly alter behavior in response to changing task demands (Kidd & Steinglass, 2012).  
Deficits in this area have been identified in acutely ill individuals with AN and, in many 
cases, in weight-restored AN individuals as well (Giovanni et al.; Roberts, Tchanturia, & 
Treasure, 2010; Sarrar et al., 2011; Steinglass et al., 2006; Tchanturia et al., 2004).  
 The persistent deficits seen in set-shifting have led some investigators to suggest 
that poor set-shifting may be an enduring trait, or even an endophenotype, associated 
with AN (Holliday, Tchanturia, Landau, Collier, & Treasure, 2005).  At the same time, 
the effects of starvation on set-shifting are not entirely understood.  Though initial weight 
restoration is not typically associated with set-shifting improvements, individuals who 
have recovered from AN do show partially improved set shifting performance, relative to 
those with acute illness (Holliday et al., 2005; Tchanturia et al., 2012; Tchanturia et al., 
2004). Furthermore, 18-hour fasting in healthy individuals who have never had AN has 
been associated with poorer set-shifting performance (Pender, 2011); this raises the 
'.!!!
question of whether the deficit in AN may be influenced by shorter-term energy 
restriction and/or longer-term energy imbalance and significant weight loss.  While AN 
individuals display deficits in set-shifting, the extent to which this represents a trait of the 
individual, a response to short- and long-term starvation, or a combination of these 
influences is not understood. 
1.7.2 Memory 
 In addition to impairments in cognitive flexibility, the domain of memory has also 
been implicated as an area of concern for individuals with AN.  Immediate and delayed 
recall tasks that require participants to recount verbally presented information have 
frequently been used to assess memory.  These tasks assess short and longer-term explicit 
memory, respectively.  Several investigators have noted impaired memory performance 
during acute AN, with some studies noting an improvement following weight restoration 
and others noting no significant change (Green et al., 1996; Kingston et al., 1996; Moser 
et al., 2003; Nikendei et al., 2011).  The specific type of memory task used may impact 
performance, with AN individuals more likely to perform poorly on memory tasks that 
require the processing of contextual information (Nikendei et al., 2011).  Deficits in 
memory performance are hypothesized to be related to alterations in hippocampal 
function in individuals with AN (Nikendei et al., 2011).  
1.7.3 Visuospatial Performance 
  Another cognitive abnormality seen in these individuals is visuospatial 
performance (Kidd & Steinglass, 2012; Kingston et al., 1996; J. Steinglass & Glasofer, 
2011).  Performance on visuospatial tasks often involves duplication of complex visual 
figures. Some studies suggest that visuospatial deficits persist following weight 
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restoration, while others suggest they may normalize (Braun & Chouinard, 1992; Jones, 
Duncan, Brouwers, & Mirsky, 1991; Szmukler et al., 1992).  It has been proposed that 
while individuals with AN pay overly close attention to detail, they often display 
difficulty with global processing, or the ability to recognize the larger, overall context 
(Lopez, Tchanturia, Stahl, & Treasure, 2008; J. Steinglass & Glasofer, 2011). 
1.8 Leptin and Cognitive Function 
 While regulation of energy intake and expenditure may be a primary function of 
the hormone leptin, evidence suggests that this hormone influences other areas of 
functioning as well (Morrison, 2009).  Leptin receptors are particularly dense in brain 
areas associated with appetite, such as the hypothalamus, however these receptors are 
also present in areas associated with learning and memory, such as the hippocampus and 
several cortical regions (Burguera et al., 2000).   
 Research in rodents suggests a clear link between leptin levels and performance 
on tasks designed to measure learning and memory.  Initially, it was shown that leptin 
receptor-deficient rats displayed poorer performance on tasks assessing learning and 
memory, such as the Morris water maze task, thought to primarily assess spatial memory 
(Li et al., 2002).  Further research has indicated that the administration of low-level doses 
of leptin to rats, on top of circulating endogenous leptin, was associated with better 
performance on tasks measuring learning and memory, including the water maze task 
(Gisou, Soheila, & Nasser, 2009; Oomura et al., 2006).  On the other hand, the 
administration of high-level doses of leptin, on top of circulating endogenous leptin, was 
not associated with enhanced task performance (Gisou et al., 2009; Oomura et al., 2006).  
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These findings have been taken to suggest an optimal level of leptin associated with 
enhanced memory performance in rats. 
 Additional studies have aimed to clarify the brain region(s) specifically associated 
with the effects of leptin on memory in rodents.  These studies have found that leptin 
administered directly to the hippocampus improves performance on memory tasks in a 
dose-dependent manner, with mid-level doses of leptin associated with optimal memory 
enhancement (Farr, Banks, & Morley, 2006; Gisou et al., 2009).  Specifically, it appears 
that leptin influences memory performance in rodents by targeting the cellular 
mechanism of long-term potentiation within the hippocampus, with particular 
concentrations of leptin providing the greatest effect (Li et al., 2002; Oomura et al., 
2006). 
 The research on leptin and cognitive functioning in humans is much more limited 
in scope; however, much of the evidence thus far seems consistent with the animal 
literature.   Importantly, while the animal literature suggests a causal link between leptin 
and cognitive performance, the findings in humans have thus far been correlational.  
Furthermore, it is important to keep in mind that leptin does not function singularly, but 
rather it is one variable in a larger biological system that may be related to aspects 
cognitive function. 
  The relation between leptin and cognitive function has been considered in several 
non-eating disorder populations, including a sample of HIV-infected men as well as 
elderly adults, populations that tend to show lower leptin levels than healthy, young 
adults (Huang et al., 2007; Gunstad et al., 2008; Holden et al., 2009).  The study of HIV-
infected men considered several domains of cognitive functioning, including memory, 
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learning, problem solving, and motor ability, by aggregating data from several relevant 
measures for each domain score (Huang et al., 2007).  A relation between leptin and the 
memory domain was noted, with low leptin levels associated with lower memory domain 
scores, when a range of HIV-related variables were controlled.   
 Findings from studies in elderly populations have been mixed regarding the 
relation between leptin and cognition.  Gunstad et al. (2008) report that higher leptin 
levels were associated with worse performance on a task measuring executive function, 
specifically the Trails B task, when considered cross-sectionally.  Holden et al. (2009), on 
the other hand, classified elderly adults into lower and higher leptin groups, identifying a 
greater level of longitudinal cognitive decline in the lower leptin group after five-year 
follow-up, when a test including multiple cognitive domains was considered.  While this 
analysis was based on a categorical leptin variable, Holden et al. note that it was at the 
extremes of the continuous leptin distribution that a stronger relationship between leptin 
and cognition was apparent.  The discrepancy in study findings may be due to a non-
linear relationship between leptin and cognitive function – such as that seen in rodents – 
or the use of different populations, time points, and/or cognitive tasks.  While 
relationships have been identified at both extremes of the leptin distribution, individuals 
with AN in the current study will presumably have leptin levels at varying degrees below 
the normal range.   
   While the relation between leptin and cognitive function in AN has not 
specifically been explored, Sarar et al. (2011) assessed the relation between the 
neuropeptide agouti-related protein (AgRP) and a cognitive task targeting cognitive 
flexibility.  Agouti-related protein is specifically inhibited by the presence of leptin (and 
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therefore is higher when leptin levels are lower) and has an opposite, orexigenic effect on 
appetite.  Sarar et al. reported a strong correlation between AgRP and performance on the 
cognitive flexibility task, with higher levels of AgRP associated with lower cognitive 
flexibility scores.   
 Additionally, Kingston et al. (1996) considered the link between cognitive 
function and percent of premorbid body weight in AN– a relative weight variable similar 
to (and in the opposite direction of) WS. These researchers considered this relationship 
across several domains of cognitive functioning, and found that the closer an AN 
individual was to her premorbid body weight, the higher her memory and learning 
domain scores.  
 While the relationship between leptin and cognitive deficits in AN have not been 
explored, the scope of cognitive deficits reported in these individuals suggests the need 
for a more comprehensive understanding of the biological mechanisms at hand. 
1.9 The Present Study 
 The present study evaluated the relationship between weight status and leptin and 
to see if such variables predicted cognitive function in AN, either during acute AN or 
following initial weight-restoration through treatment.  Given the independent 
associations found between WS and leptin and between BMI and leptin, this study aimed 
to examine the potential for these two weight status variables to individually or conjointly 
predict leptin level.  We tested whether there was an interaction between WS and BMI on 
leptin level, to determine whether BMI moderated any relationship between WS and 
leptin.  By examining both of these weight status variables in the same model, the goal 
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was to better be able to tease apart the predictive significance of relative and absolute 
weight status on serum leptin. 
   Furthermore, as discussed previously, cognitive impairments have been identified 
in AN across multiple domains, however the interpretation of these impairments is 
complicated.  Specifically, the potential for low body weight and malnutrition, as well as 
variables more intrinsic to AN, to influence cognitive performance makes it difficult to 
identify which factors contribute to observed performance.  This study aimed to evaluate 
the potential for weight status to predict cognitive performance, across several domains, 
in order to help tease apart what weight-related variables are associated with task 
performance in specific cognitive domains.  We again considered the conjoint predictive 
significance of both WS and BMI in order to evaluate the relevance of relative and 
absolute weight status in relation to cognitive performance.  In addition, as previously 
discussed, leptin has been identified as a messenger to the brain related to fat store and 
energy availability.  Leptin has also demonstrated a relationship to cognitive function in 
animals and (with more limited data) in humans.  This study therefore also aimed to test 
the predictive significance of leptin on cognitive performance in AN.   
 By considering the predictive significance of weight status and, independently, 
the predictive significance of leptin on cognitive performance in AN, we set out to 
contribute to our understanding of the relation between body weight and a weight-related 
physiological variable on cognitive performance.  Conceptually, we viewed leptin as a 
potential mediator of any relationship between weight status and cognitive performance, 
and planned to statistically test this possibility if conditions for mediation were met.  It is 
also important to keep in mind that there are likely many variables that are related to 
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cognitive performance in AN, and this study only evaluated a few of them.  Additionally, 
while findings from the present study were not intended to establish cause and effect, the 
findings should inform the literature on aspects of cognitive performance that may be 
accounted for by weight-related variables, as compared to those more closely linked with 
other aspects of AN psychopathology. 
 The present study was carried out in a sample of AN patients receiving treatment 
at an inpatient treatment facility.  This study evaluated participants at two time points: (1) 
soon after admission and (2) following initial weight restoration.  Participants completing 
the second time point gained weight to at least 90% of that expected based on height (a 
minimally acceptable weight in absolute terms).  By examining the relationship at both 
time points, we set out to to determine if the relationship between weight-status, leptin, 
and cognitive performance was the same at each time point.  Given that all of our 
predictor variables (weight status variables and leptin) were expected to change between 
time points, it became especially interesting to consider these relationships again.  It is 
possible that the relationship itself could be influenced by the emaciated state of an 
individual at admission, such that the relationship would look different following weight 
restoration.  Additionally, it is presumed that patients had similar (minimally healthy) 
BMIs to one another at the second time point, while greater variability remained in level 
of WS.  Evaluating the same relationships following weight restoration allowed us to test 
for the predictive effects of weight-related variables on cognitive performance when 
individuals were at healthy absolute body weights.     
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1.9.1 Hypotheses 
 Hypothesis 1: We hypothesized that weight status (WS, BMI, and/or their 
interaction) would predict leptin level, at (1) admission and (2) following weight 
restoration.  In the case of main effects, we hypothesized that higher WS and/or lower 
BMI would be associated with lower leptin levels.  
 Hypothesis 2: We hypothesized that weight status (WS, BMI, and/or their 
interaction) would predict cognitive task performance. Cognitive tasks included measures 
of memory (California Verbal Learning Test; Letter-Number Sequencing), cognitive 
flexibility (Trail Making Task), and spatial reasoning (Block Design1), at (1) admission 
and (2) following weight restoration.  In the case of main effects, we hypothesized that 
higher WS and/or lower BMI would be associated with poorer cognitive performance. 
 Hypothesis 3: We hypothesized that leptin level would predict cognitive task 
performance, at (1) admission and (2) following weight restoration.  We predicted that 
lower leptin levels will be associated with poorer cognitive performance. 
 Hypothesis 4 (secondary hypothesis): If conditions for a mediation analysis were 
met, we hypothesized that leptin would mediate the relationship between weight status 
and cognitive task performance at (1) admission and (2) following weight restoration.   
CHAPTER 2: METHODS 
2.1 Participants 
 This study included the analysis of data collected from 64 women who met DSM-
IV criteria for AN (other than the amenorrhea criterion) at inpatient admission to the 
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1 The Block Design task was only administered once, following weight restoration.  Therefore, analyses 
involving Block Design will be available following weight restoration but not at the admission time point. 
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General Clinical Research Unit (GCRU) at Columbia University Medical Center.  
Specifically, data were included from female participants with AN enrolled in the 
ongoing protocol  “A Neurocognitive Model of Anorexia Nervosa;” for the purposes of 
this paper, this protocol will be referred to as “Protocol A.”  A subset of 33 of the original 
64 women were also enrolled in the protocol “Behavioral Assessment of Reinforcing 
Effects of Exercise in Patients with Anorexia Nervosa;” a subset of analyses will only 
include this smaller sample of participants.  For the purposes of this paper, the latter 
protocol will be referred to as “Protocol B.”   The current study only considered data 
from female participants because of the expected difference in hormone levels between 
males and females and because AN is quite rare in males, with epidemiological studies 
suggesting approximately 10% of reported cases to be male (Lucas, Beard, O'Fallon, & 
Kurland, 1991).   
 Many of the inclusion/exclusion criteria were adapted from Protocol A and 
Protocol B.  Inclusion/exclusion criteria are provided below: 
Inclusion Criteria 
 
Method of Ascertainment 
Enrollment in Protocol A Protocol database 
Female Self-report 
The following criteria are adapted from Protocol A and apply to ALL participants in the 
current study: 
DSM-IV diagnosis of anorexia nervosa 
(restricting or binge-purge subtype), with 
or without amenorrhea at the time of 
admission 
Semi-structured diagnostic interview (SCID-
I), Eating Disorders Examination (EDE) 
 
Age 16 – 45 Birth date 
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Inpatient at the GCRU at Columbia 
University Medical Center 
Medical record 
Medically stable Determination by clinical team 
Participants must have signed informed 
consent document indicating that they 
understand the purpose of and procedures 
required for the study and are willing to 
participate in the study. 
Informed consent obtained at enrollment 
The following criteria are adapted from Protocol B and apply only to participants 
included in the subset of leptin analyses: 
Enrollment in Protocol B Protocol database 
Age 16-40 Birth date 
 
 
Exclusion Criteria 
 
Method of Ascertainment 
The following criteria are adapted from Protocol A and apply to ALL participants in the 
current study 
Psychotic disorder; current substance 
abuse disorder 
 
SCID-I/P 
History of concussion, seizure disorder, or 
other neurological illness 
Screening questionnaire 
History of learning disability Clinical Interview 
Acute suicidality Clinical Interview 
The following criteria are adapted from Protocol B and apply only to participants 
included in the subset of leptin analyses: 
Significant current or past medical illness 
including diabetes mellitus and heart 
disease 
Clinical interview 
Pregnancy Urine pregnancy test 
If taking psychotropic medication, 
excluded if dose is not stable (i.e., has 
changed within the past 5 days) 
Clinical interview 
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2.2 Procedures 
 Data were collected from two in-progress research studies  (Protocol A and 
Protocol B) and one screening protocol taking place at the Eating Disorders Research 
Unit (EDRU) at New York State Psychiatric Institute/Columbia University Medical 
Center.  Participants with AN from Protocol A were included in the current study.  A 
subset of participants enrolled in Protocol A also enrolled in Protocol B; analyses 
involving leptin were evaluated for this subsample.  
 The EDRU provides treatment at no cost to individuals interested in and eligible 
for ongoing research protocol.  Participants for Protocol A and Protocol B were recruited 
from prospective patients who called the EDRU to request treatment for AN. As per 
routine EDRU practice, prospective patients initially completed a phone screening 
interview with a research assistant to collect demographic information as well as current 
and past medical and psychiatric information.  Prospective patients were informed of any 
ongoing EDRU protocol for which they seemed eligible, including Protocol A and/or 
Protocol B.  Interested individuals were then screened by an M.D. or Ph.D.-level clinician 
to gather further information about medical and psychiatric histories.  Participants were 
screened for eligibility under the screening protocol, “Screening Process for the Eating 
Disorders Research Clinic” and all participants gave informed consent prior to study 
participation. 
 Patients were admitted as inpatients to the Eating Disorders Service of the 
General Clinical Research Unit (GCRU) at the New York State Psychiatric Institute of 
Columbia Medical Center.  This treatment center includes a multidisciplinary team of 
psychologists, psychiatrists, dieticians, social workers, nurses, and recreational and 
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occupational therapists.  Patients participate in a variety of group therapy and individual 
therapy sessions throughout treatment.  A complete treatment course typically spans two 
to three months. 
 The GCRU does not admit patients involuntarily, and therefore all participants in 
the current study were voluntarily admitted to treatment.  The voluntary status of all 
patients included in the current study may differ from the more heterogeneous makeup of 
other hospital-based eating disorder programs.  That is, because many individuals with 
AN lack awareness of the seriousness of the condition, a subset who are unwilling to 
consent to treatment will be involuntarily committed to treatment at other programs.  
While extreme ambivalence about treatment and recovery is common among voluntary 
and involuntary patients with AN alike, it is noteworthy that the patients included in the 
current study represent a sample of voluntary patients with AN only.  Furthermore, 
because individuals included in the current study received treatment at no cost, the length 
of treatment for an individual was not directly influenced by financial factors, such as 
medical costs or insurance coverage, which typically impact treatment duration at other 
programs.  In this way, the treatment provided to patients included in the current study 
may differ from that available at other settings.    
 Treatment of AN at the GCRU includes three phases: medical stabilization, 
weight restoration, and weight maintenance.  During the medical stabilization phase, 
patient medical status is carefully assessed  (physical exam, laboratory evaluation for 
blood count and serum chemistries, EKG, vital signs, etc.), and acute abnormalities are 
addressed.  Nutritional status is also assessed and calories are prescribed with the goal 
being cessation of weight loss.  
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 Following medical stabilization, the patient enters the weight restoration phase of 
treatment.  During this phase, calories are adjusted with the goal being weight gain of two 
to five pounds each week.  The patient remains in this phase until reaching a medically 
acceptable body weight, based on the individual’s height, with a common target of 90% 
of ideal body weight.  Ideal body weight is calculated using Metropolitan Life Insurance 
Tables which identify body weights associated with the lowest mortality rates for any 
given height and gender (Metropolitan Life, 1959). 
 During the final phase of weight maintenance, nutritional needs are reevaluated 
and calories are prescribed with a goal of weight maintenance.  Patients typically stay in 
this treatment phase for four to six weeks prior to being discharged from the hospital. 
 Participants were asked to participate in Protocol A at two time points: soon after 
admission (following medical stabilization) and after weight restoration to 85-90% IBW.  
Assessment measures for Protocol A included psychological assessments and 
neuropsychological testing.  Completion of psychological assessment took approximately 
2 hours and completion of neuropsychological testing took about 3.5 hours for the full 
protocol; however, only a subset of the assessments completed for Protocol A were 
included in the current analyses.  In addition, WS was calculated for all participants 
enrolled in Protocol A at both time points (at admission and after weight restoration). 
Details on calculation of this variable are provided below.    
 For the subgroup of patients also enrolled in Protocol B, blood samples for serum 
leptin levels were collected.  The two time points for blood sample collection were the 
same as time points for Protocol A, after admission and weight restoration, however 
samples were not necessarily collected on the same date as participation in Protocol A.  It 
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is expected that on average blood samples will have been collected within two weeks of 
neuropsychological testing, and the actual time frame between participation dates will be 
reported in the study write-up.  Details regarded the blood draw are included below. 
 Participants completed two structured psychiatric interviews (listed below) at 
each of the two time points.  One of the interviews assessed general psychological 
pathology and the other assessed eating disorder-specific pathology.  Research assistants 
trained in the administration of each of these, and continually monitored for high inter-
rater reliability, carried out the assessments.   
 Participants also completed a neuropsychological battery of assessments at both 
admission and weight restoration time points.  The neuropsychological battery was 
administered by trained research assistants.  Five of the neuropsychological measures 
(listed below), included as a part of the larger assessment battery, were included as 
measures of cognitive performance in the present study.   
2.3 Measures 
2.3.1 Neuropsychological Measures Completed at Both Time Points 
2.3.1.1 Assessment of Memory 
 California Verbal Learning Test , Second Edition (CVLT): This test is a 
frequently used clinical and research measure used for the assessment of short-term and 
longer-term memory following both free and cued recall (Delis, Kramer, Kaplan, & Ober, 
2000).  The participant is read a list of 16 nouns by the examiner and asked to recall the 
words over a total of five learning trials.  All words are taken from one of four semantic 
categories:  tools, fruits, clothing, spices and herbs.   The participant is prompted to recall 
the words in any order after each of the trails (immediate recall) and the total words 
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recalled over all five trials is taken as an overall measure of immediate recall (total 
immediate recall trails 1-5), while the slope of the learning curve over the five trials is 
taken as a measure of learning (learning slope trials 1-5).  
 Following the immediate recall procedures, the participant is read a new list of 
“interference” words and asked to recall these words.  The participant is then prompted to 
recall the items from the first set of words in any order (short delay free recall) and 
subsequently following prompts for each of the four semantic categories (short delay 
cued recall).  After a delay, the participant is again asked to recall the items from the first 
set of words in any order (long delay free recall) and subsequently following prompts for 
each of the four semantic categories (long delay free recall).   
 The CVLT has demonstrated strong construct validity for episodic verbal learning 
and memory (Alexander, Stuss, & Fansabedian, 2003; Baldo, Delis, Kramer, & 
Shimamura, 2002).  It has also demonstrated high test-retest reliability in non-clinical 
patients (Benedict, 2005; Woods, Delis, Scott, Kramer, & Holdnack, 2006).  The CVLT 
also demonstrates high convergent validity with the Wechsler Memory Scale, Revised 
(WMS-R), with high correlations between many indices on each of these memory 
assessments (Delis, Cullum, Butters, Cairns, & Prifitera, 1988).   Although the CVLT has 
not been used frequently with individuals with acute AN, the WMS-R consistently 
identifies deficits in AN individuals compared to healthy controls in immediate and 
delayed recall task performance, suggesting this task may also capture such impairments 
(Bayless et al., 2002; Mathias & Kent, 1998; Nikendei et al., 2011).   
 Letter-Number Sequencing subtest of the Wechsler Adult Intelligence Scale 
(WAIS):  Letter-number sequencing is a subtest of the WAIS-III, a general measure of 
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intellectual functioning (David Wechsler, 1997).  This subtest assesses auditory working 
memory, testing an individual’s short-term memory capacity and ability to rearrange 
information sequentially.  For each trial, participants are read a series of letters and 
numbers in random order (e.g., 74E8AI) and asked to repeat them back placing first the 
numbers in order and then the letters in order (e.g., 478AEI).  Participants are scored 
based on the number of correct trials, with trial difficulty increasing throughout the task.  
This subtest has shown good internal consistency, high test-re-test reliability, and high 
criterion validity, when compared with the working memory index of the WMS-III 
(Sattler & Ryan, 2009).  
2.3.1.2 Assessment of Cognitive Flexibility 
 Trail Making Test:  This task assesses executive function, planning, and set 
shifting.  In part A, participants are asked to draw a line connecting a series of 25 
randomly arranged numbers in sequential order (Reitan, 1986).  In part B, participants are 
asked to draw a line alternating sequentially between 25 randomly arranged (e.g. 
connecting 1 to A to 2 to B).  Scoring is based on completion time for each part.  Part A 
performance relates to visuoperceptual ability and motor speed, while part B performance 
is associated with these constructs as well as task-switching ability (Crowe, 1998; 
Sanchez-Cubillo et al., 2009). The Trail Making Test has demonstrated high test-retest 
reliability for both parts (Spreen & Strauss, 1991).  Individuals with acute AN have 
demonstrated poor trails B performance (Kingston et al., 1996; Kate Tchanturia et al., 
2004). In addition to scores for each part, a B-A difference score minimizes the influence 
of visuoperceptual ability and motor speed, providing a purer measure of task-switching  
(Sanchez-Cubillo et al., 2009); this value will also be considered in the current study. 
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2.3.2 Neuropsychological Measures Completed Only Following Weight Restoration 
2.3.2.1 Assessment of Visuospatial Ability 
 Block design subtest of Wechsler Abbreviated Scale of Intelligence (WASI): The 
block design task is a subtest of a larger assessment of general intellectual functioning, 
the WASI (Wechsler, 1999).  The block design subtest is included as a measure of 
visuospatial ability.  Participants are asked to construct geometric patterns based on a 
presented model using two-color cubes within a time limit.  Participants are scored based 
on the number of correct trials, with trial difficulty increasing throughout the task.  This 
task shows high test-retest reliability (Strauss, Sherman, & Spreen, 2006).   
2.3.3 Neuropsychological Measures Completed Only at Admission 
2.3.3.1 Assessment of General Intellectual Functioning 
 Wechsler Test of Adult Reading (WTAR): This is a word pronunciation test 
during which participants are asked to read a list of 50 words, including many items with 
unusual spelling (Wechsler, 2001).  This task was codeveloped with and normed to the 
Wechsler Adult Intelligence Scale–Third Edition (WAIS!III; Wechsler, 1997).  The 
WTAR is a brief assessment that is used as an estimation of WAIS-III verbal, 
performance, and full-scale intelligence quotient (IQ). The WTAR is often used as an 
estimate of premorbid ability because reading ability often remains intact for individuals 
with various brain-based disorders.  In general, IQ is also thought to remain intact for 
individuals with AN (Steinglass & Glasofer, 2011).  The WTAR shows excellent internal 
consistency and stable test-retest reliability.  Furthermore, it is highly correlated (r > .70) 
with measures of verbal, performance and full-scale IQ (Strauss, 2006).  Because IQ is 
often related to performance on other cognitive task (Diaz-Asper, Schretlen, & Pearlson, 
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2004), WTAR score will be considered as a potential covariate in the present study. 
2.3.4 Psychological Assessments Completed at Both Time Points 
2.3.4.1 Assessment of Eating Disorder Psychopathology 
 Eating Disorder Examination (EDE): This is an investigator-based semi-
structured interview that measures eating disorder psychopathology.  It is considered the 
“gold standard” in eating disorder assessment.  The EDE assesses frequency and severity 
of eating disorder psychopathology across the domains of restraint, eating, shape, and 
weight. The EDE has demonstrated good test-retest and inter-rater reliability as well as 
good discriminant validity (Cooper, Cooper, & Fairburn, 1989; Cooper & Fairburn, 1987; 
Rizvi, Peterson, Crow, & Agras, 2000). 
Assessment of General Psychopathology 
 Structured Clinical Interview for DSM-IV –TR Axis I Disorders (SCID I): This is 
a semi-structured investigator-based interview that assesses for the presence or absence 
of the major DSM-IV-TR Axis I disorders, including mood, anxiety, psychotic, 
substance, and eating disorders (First, Spitzer, Gibbon, & Williams, 1996).  The SCID I 
is a commonly used assessment tool and has shown adequate interrater and test-retest 
reliability for all disorders (Zanarini & Frankenburg, 2001).  It is directly based on the 
diagnostic criteria provided by the DSM, so its construct validity is theoretically as valid 
as the diagnostic categories themselves. 
2.3.5 Leptin Levels 
 Venous samples were obtained in the morning after overnight fast and 
immediately centrifuged, with plasma separated from red blood cells.  For each blood 
draw the total amount of blood required was less than 15 cc, or one tablespoon.  Plasma 
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and red blood cell samples were stored at –70oC until subsequent analysis.  Assay for 
leptin was completed at the Nathan Kline Institute for Psychiatric Research.  
2.3.6 Weight Suppression  
 Participants were asked to report their highest weight ever since reaching their 
current height (not due to pregnancy or medical conditions). Current weight and height 
information were collected from participant medical records.  Weight suppression was 
calculated as the difference between the participant’s current weight and their reported 
previous highest weight.  The validity of recalled past weights has been supported by 
previous research (Tamakoshi et al., 2003), including a study of adolescents with AN and 
BN reporting a correlation of .92 between highest measured premorbid weight from 
school records and highest recalled premorbid weight (there were no differences between 
diagnostic groups; Swenne, Belfrage, Thurfjell, & Engström, 2005). Any discrepancy 
between recalled and actual highest weight should be small relative to large signal 
produced by WS.  In fact, use of recalled highest past weight in the calculation of WS is 
standard (Butryn, Lowe, Safer, & Agras, 2006; Carter, McIntosh, Joyce, & Bulik, 2008;  
Herzog et al., 2010; Keel & Heatherton, 2010;  Lowe et al., 2011; Lowe, Davis, Lucks, 
Annunziato, & Butryn, 2006;  Lowe, Thomas, Safer, & Butryn, 2007; Zunker et al., 
2010).   
2.3.7 Body Mass Index   
 Body Mass Index was calculated based on measured height and weight taken 
from medical records, using the formula kilograms/meters squared.   
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2.3.8 Demographic Data 
 Demographic data were collected from a brief demographic questionnaire at the 
admission time point only.  Information included age, ethnicity, race, years of education, 
and years of illness. 
2.4 Data Analysis  
 Descriptive statistics were calculated for all demographic, neuropsychological, 
psychological, physiological, and weight status variables.  Transformations of outcome 
variables for subsequent analyses were considered on the basis of the sample distribution, 
outlier analyses, and analyses of assumptions for multiple regression. Repeated measures 
t-tests were computed for all variables tested at both admission and weight restoration 
time points to further characterize the sample.  A Pearson’s correlation matrix was 
computed among variables; any variable significantly correlated with an outcome 
variable was considered as a potential covariate in the regression analyses discussed 
below.   
 An alpha level of .05 was used for all analyses.  An adjustment to alpha was not 
made for the multiple tests included in the current study because analyses were 
considered exploratory and because the analyses were expected to be underpowered (see 
power section below).  Additionally, because analyses were underpowered, we 
speculatively discuss results based on the assumption that a medium to large effect size 
may be meaningful, in addition to discussing results in terms of statistical significance. 
  Hypothesis 1: We hypothesized that weight status (WS, BMI, and/or their 
interaction) would predict leptin level, at (1) admission and (2) following weight 
restoration.  In the case of main effects, we hypothesized that higher WS and/or lower 
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BMI would be associated with lower leptin levels.  
 Analysis: A multiple linear regression analysis was conducted with WS, BMI, and 
their interaction (WS*BMI) as predictor variables and leptin as the outcome variable (1) 
at admission and (2) after weight restoration. The interaction term was calculated by first 
mean-centering and then multiplying the WS and BMI variables.  When an interaction 
effect was not identified, the analysis was re-run without the interaction term and main 
effects for WS and BMI were tested.  
 Hypothesis 2: We hypothesized that weight status (WS, BMI, and/or their 
interaction) would predict cognitive task performance. Cognitive tasks included measures 
of memory (California Verbal Learning Test; Letter-Number Sequencing), cognitive 
flexibility (Trail Making Task), and spatial reasoning (Block Design), at (1) admission 
and (2) following weight restoration.  In the case of main effects, we hypothesized that 
higher WS and/or lower BMI would be associated with poorer cognitive performance. 
 Analysis: A multiple linear regression analysis was conducted with WS, BMI, and 
their interaction (WS*BMI) as predictor variables and cognitive performance as the 
outcome variable, separately for each cognitive performance score, (1) at admission and 
(2) after weight restoration. The interaction term was calculated by first mean-centering 
and then multiplying the WS and BMI variables.  When an interaction effect was not 
identified, the analysis was re-run without the interaction term and main effects for WS 
and BMI were tested. 
 Hypothesis 3: We hypothesized that leptin level would predict cognitive task 
performance, at (1) admission and (2) following weight restoration.  We predicted that 
lower leptin levels will be associated with poorer cognitive performance. 
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  Analysis: A multiple linear regression analysis was conducted with leptin as a 
predictor variables and cognitive performance as the outcome variable, separately for 
each cognitive performance score, (1) at admission and (2) after weight restoration.  
 Hypothesis 4 (secondary hypothesis): If conditions for a mediation analysis were 
met, we hypothesized that leptin would mediate the relationship between weight status 
and cognitive task performance at (1) admission and (2) following weight restoration.   
 Analysis: If conditions for mediation were met (weight status predicted cognitive 
function; weight status predicted leptin; leptin predicted cognitive function), the Baron 
and Kenny model would be used to test for mediation, (1) at admission and (2) after 
weight restoration. Because conditions for mediation were not met, this model was not 
tested. 
2.5 Power Analysis 
 A power analysis was conducted using the G*Power version 3.1.3 for Mac for 
each of the hypotheses.  There was little prior research to estimate strength of the effect, 
so a medium effect size was used (f2 = .15). For all analyses, alpha was set to .05 and 
power was set to .80.  The greatest number of participants needed for any of the primary 
hypotheses was 77.  Due to sample availability, this study was underpowered, requiring a 
medium to large effect size in order to detect a relationship if one were present.  
Specifically, an effect size of f2 = .18 would be required to detect an effect in our most 
complicated primary analyses including the full Study A sample of 64 participants.  An 
effect size of f2  = .32 would be needed for hypotheses using the smaller, Study B sample 
of 33 participants (i.e., all analyses involving leptin).  Furthermore, Study A and B 
sample sizes were calculated based on data available at the admission time point. Fewer 
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participants had data following weight restoration, suggesting it was more difficult (and 
therefore would require a greater effect size) to identify a significant effect in analyses 
completed at this time point. 
2.6 Institutional Review Board Approval 
 The analysis of this data was approved by the New York State Psychiatric 
Institute and Drexel University Office of Human Research. 
CHAPTER 3: RESULTS 
 Demographic and clinical characteristics are presented in Table 1.  Participants 
included 64 women who on average were in their mid-twenties, with a mean duration of 
illness of approximately eight years.  The majority of participants were Caucasian 
(90.6%), while 7.8% were Hispanic and 1.6% were Asian.  Participants included 31 
individuals  (48.4%) with the restricting subtype of AN (AN-R) and 33 individuals 
(51.6%) with the binge-purge subtype of AN (AN-BP).  Participant current cormorbid 
diagnoses, based on the SCID assessment at admission, included Major Depressive 
Disorder (10.9%; n = 7), Social Phobia (9.4%; n = 6), Post Traumatic Stress Disorder 
(8%; n = 5), Specific Phobia (3.1%; n = 2), Obsessive Compulsive Disorder (3.1%; n = 
2), Dysthymic Disorder (1.6%, n = 1), and Panic Disorder (1.6%, n = 1).  
 Descriptive statistics for neuropsychological, physiological, and weight status 
variables are also presented in Table 1. Paired-samples t-tests are reported in Table 1 for 
variables collected both at admission and post-weight restoration time points. On 
average, the admission time point was 50.57 days (SD = 15.39) days prior to the post-
weight restoration time point. The Protocol B collection date was an average of 4.13 days 
from the Protocol A collection date at admission and 8.45 days at post-weight restoration.  
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Intercorrelations between all variables at admission are presented in Table 2, and 
intercorrelations between all variables following weight restoration are presented in Table 
3.  Independent samples t-tests comparing neuropsychological, physiological, and weight 
status variables between AN-R and AN-BP individuals are reported in Table 4.  For 
analyses that do not include leptin, analyses reported are based on variables collected at 
the time of cognitive measures (Protocol A variables).  
 Examination of the assumptions of regression suggested that several variables (at 
admission: WS for protocol A and B, leptin; post-weight restoration: WS for protocol A, 
letter number sequencing) did not satisfy criteria for a normal distribution (skewness and 
kurtosis not exceeding an absolute value of 1), therefore log, square root, and inverse 
transformations were computed for each variable and the transformation that brought the 
distribution closest to normality was selected.   In most cases, the variables were 
transformed using a log transformation, with the exception of post-weight restoration WS 
for Protocol A, which was transformed using a square root transformation.  After 
transformation, all variables satisfied criteria for a normal distribution (unless otherwise 
reported), and the transformed variables were used in the analyses reported below.  All 
regression assumptions of linearity, homoscedasticity, non-multicollinearity, and 
normality of error were met.  For variables with extreme outliers (i.e., outliers that exceed 
three times the interquartile range), analyses were run both including and excluding the 
extreme outliers. For regression analyses including variables that differed by AN subtype 
(AN-R; AN-BP), subtype was included as a covariate.  For analyses involving leptin, 
weight status variables reported are based on those collected at the time of leptin 
collection (Protocol B weight status variables).  For analyses that do not include leptin, 
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weight status variables reported are based on those collected at the time of cognitive 
measures (Protocol A weight status variables).  
3.1 Hypothesis 1: Weight Status and Leptin Level 
 Results from regression analyses of weight status and leptin are presented in 
Tables 5 and 6.  At admission, WS predicted leptin level, controlling for BMI, with 
higher weight suppression associated with lower leptin level.  Similarly, BMI predicted 
leptin level, controlling for WS, with lower BMI associated with lower leptin level (see 
Figure 1).  There was no interaction between WS and BMI on leptin.   
 At post-weight restoration, the distribution of BMI values for Protocol B were 
positively skewed and leptokurtic.  The distribution also included one extreme outlier at 
the upper end of the distribution, which seemed to contribute to the non-normality of the 
distribution. Transformations were not effective at reducing skewness or kurtosis; 
however, exclusion of the extreme outlier brought the distribution to normality.  Analyses 
were run with and without the extreme outlier.  Post-weight restoration, WS predicted 
leptin level, controlling for BMI, with higher WS associated with lower leptin level (see 
Figure 2; note that due to significant changes in leptin between time points, the Y-axis is 
scaled differently for Figure 1 and Figure 2).  BMI did not predict leptin level; this 
finding may be influenced by the limited range of BMI values at this time point (with 
outlier: 18.91 – 22.5; without outlier: 18.91 – 20.55), which is consistent with a common 
target weight restoration goal for patients of 90% Ideal Body Weight.  There was no 
interaction between WS and BMI on leptin.  The pattern of results did not change when 
the outlier was removed or when AN subtype was included as a covariate. 
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3.2 Hypothesis 2: Weight Status and Cognitive Task Performance 
 Results from regression analyses of weight status and cognitive task performance 
(CVLT measures; Trails B-A Difference score; Letter Number Sequencing; Block 
Design) are presented in Tables 5 and 6. The distribution of standardized CVLT long 
delay free recall scores was negatively skewed and leptokurtic.  The distribution also 
included two extreme outliers that seemed to contribute to the non-normality of the 
distribution.  Transformations were not effective at reducing skew or kurtosis; however, 
exclusion of the extreme outliers brought the distribution to normality.  Analyses were 
run with and without the extreme outliers.  At admission, weight status (BMI, WS, and/or 
their interaction) did not significantly predict performance on CVLT immediate recall, 
CVLT short delay free recall, CVLT long delay free recall, CVLT long delay cued recall, 
CVLT learning slope, Trails B-A Difference score, or letter number sequencing; WS 
significantly predicted CVLT short delay cued recall, with lower WS associated with 
better recall. The pattern of results did not change when the outlier was removed or when 
AN subtype was included as a covariate. 
 Post-weight restoration, the distribution of BMI values for Protocol A were 
positively skewed and leptokurtic.  The distribution also included one extreme outlier at 
the upper end of the distribution, which seemed to contribute to the non-normality of the 
distribution.  Transformations were not effective at reducing skew or kurtosis; exclusion 
of the extreme outlier resolved problems of skew, however the distribution remained 
leptokurtic. Because linear regression tends to be robust to nonnormality, interpretation 
of results should not be greatly impacted.  Analyses were run with and without the 
extreme outlier.  Post weight restoration, weight status variables did not significantly 
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predict performance on any of the cognitive measures tested, including CVLT immediate 
recall, CVLT short delay free recall, CVLT short delay cued recall, CVLT long delay 
free recall, CVLT long delay cued recall, CVLT learning slope, Trails B-A Difference 
score, letter number sequencing, and Block Design. The pattern of results did not change 
when the outlier was removed or when AN subtype was included as a covariate. 
3.3 Hypothesis 3: Leptin and Cognitive Task Performance 
 Results from regression analyses of leptin on cognitive task performance are 
presented in Tables 7 and 8.  At admission, leptin did not significantly predict any of the 
cognitive performance measures tested (CVLT measures; Trails B-A Difference score; 
Letter Number Sequencing).  Analyses for CVLT long delay free recall were completed 
both with and without extreme outliers.  Post-weight restoration, leptin also did not 
significantly predict any of the cognitive performance measures tested (CVLT measures; 
Trails B-A Difference score; Letter Number Sequencing; Block Design); however, the 
effect of leptin on block design performance did approach statistical significance. The 
pattern of results did not change when AN subtype was included as a covariate. 
CHAPTER 4: DISCUSSION 
 Anorexia nervosa (AN) is a debilitating psychiatric illness that is highly resistant 
to treatment. Individuals with this disorder display cognitive impairments on a range of 
neuropsychological tests; however, the interpretation of such impairments is complicated 
by the potential for starvation and low body weight to influence performance.  The extent 
to which particular cognitive deficits are related to physiological influences of weight 
status as compared to impairments more intrinsic to AN psychopathology is not well 
understood.  
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 The current study aimed to tease out the extent to which performance on 
particular cognitive measures was related to weight status among individuals with AN. 
Both absolute and relative measures of body weight (BMI; WS) were considered as 
components of weight status, and leptin, a hormone produced by adipose tissue, was 
evaluated as a potential physiological marker of weight status. The current study aimed to 
evaluate the relationship between weight status and leptin and to see if such variables 
predicted cognitive function in AN, either during acute AN or following initial weight-
restoration through treatment.  Results indicated that weight status was associated with 
leptin at both time points.  However, neither weight status nor leptin were associated with 
cognitive task performance among the domains tested.     
 The association between weight status and leptin at both time points is intriguing.  
At admission, both BMI (controlling for WS) and WS (controlling for BMI) were 
associated with leptin; low BMI and high WS were each associated with low levels of 
serum leptin.  Following initial weight restoration, WS, but not BMI was associated with 
leptin, again with high WS associated with low levels of serum leptin.  The lack of 
association between BMI and leptin following weight restoration may be accounted for 
by the limited range in BMI values at this time point; because patients were provided 
with a common weight restoration goal of 90% Ideal Body Weight, there was limited 
variability in absolute body weight at this time point, potentially limiting the ability to 
detect an effect of BMI. 
 Although a positive association between BMI and leptin is well established in 
individuals with eating disorders and the general population (Ferron et al., 1997; Ruhl et 
al., 2004) the relationship between WS and leptin has not been well studied.  Findings 
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from the current study suggest that the further an individual is from their previous highest 
weight, the lower their leptin level, even when BMI is controlled.  This is consistent with 
findings from a pilot study (Klein et al., 2011, July), which included a subsample of 
patients participating in the current study; Klein and colleagues (2011, July) reported a 
negative association between leptin and WS among AN individuals following weight 
restoration.  The current study expands upon these findings by demonstrating that WS 
remains significantly associated with leptin, even when BMI is controlled.  Furthermore, 
this study demonstrates that WS is associated with leptin not only after weight restoration 
but also during the acute phase of the disorder.   
 The association between WS and leptin suggests that leptin is not only a marker 
of current body fat levels but also is associated with the discrepancy between past highest 
and current body weight.  Leptin is thought to contribute to the maintenance of energy 
and weight homeostasis, with an especially strong role in alerting the brain to an ongoing 
state of starvation (Kelesidis et al., 2010; Prentice et al., 2002).  Leptin has been shown to 
change more drastically in response to an energy deficit than to an energy surplus (Chin-
Chance et al., 2000). The finding of an association between WS and leptin, above and 
beyond the association with BMI, suggests that the body defends against weight loss 
from a previous highest weight, not just to a medically healthy level (as defined by 
absolute body weight standards).  Because low leptin is a signal that biologically should 
promote a desire to eat, and subsequent weight gain, individuals with AN who are highly 
weight suppressed may experience a stronger drive to eat as well as a greater metabolic 
pull towards weight gain.  Given that weight gain is a greatly feared consequence for 
individuals with AN, individuals who are still weight suppressed following treatment 
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may face additional clinical challenges as they continue to experience a biological 
inclination towards weight gain while attempting to maintain their body weight.  Thus 
weight gain to a minimally healthy absolute body weight is not necessarily sufficient to 
restore leptin to normal levels.  It seems that weight gain targets that factor in both 
absolute and relative weight status would allow individuals to experience biological 
drives that are consistent with treatment-related behavioral goals (i.e., weight 
maintenance following treatment without an undue degree of food restriction or 
exercise); the extent to which such targets would enhance treatment outcomes in AN is an 
important empirical question. 
 Although weight status and leptin were related in the current study, weight status 
was not associated with cognitive performance across measures associated with memory, 
cognitive flexibility, or visuospatial ability (with the exception of short delay cued recall 
memory at admission).  Because only one of the several memory (CVLT) variables tested 
displayed a relationship with weight status at admission, it should be interpreted 
cautiously. At admission, WS was significantly associated with CVLT short delay cued 
recall, with lower WS associated with better recall, controlling for BMI; the association 
did not hold up post-weight restoration.  This subtest of the CVLT measures the ability 
for an individual to recall items from a list of words after a brief delay, in response to 
cues related to the semantic categories of words presented in the list.  It may be that 
during the acute phase of AN, this ability to recall words in response to cues following a 
brief delay is associated with degree of WS.  At the same time, this relationship may be 
accounted for by a Type 1 error, rather than a true effect, given the many analyses 
completed in the current study.  
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 The extent to which cognitive performance on each of the measures tested was 
actually impaired becomes a relevant consideration to the interpretation of findings.  The 
current study did not include a control group, and therefore comparisons between scores 
on study tasks and published normative data were made when possible.  On average, 
participants did not score in an impaired range on the neuropsychological tasks included 
in the current study.  For instance, 7 out of 9 cognitive variables tested – including all 
CVLT variables and block design – were reported using a Z-score (standard score) or T-
score in the current study.  As a group, participants performed about average as compared 
to a normative sample; in fact, average participant performance in the current sample was 
within one third of a standard deviation of average performance in a normative sample 
for each of these 7 cognitive variables at both time points. In cases where a raw score, 
rather than standardized score, was reported, comparisons to other healthy control 
samples were made; once again, participant performance was not obviously outside of a 
normative range  For letter-number sequencing, average participant scores were also  
within one third of a standard deviation of average performance in a normative sample 
(David Wechsler, 1997).  For Trails Making Test Difference score, average participant 
scores in the current study were within one sixth of a standard deviation of average 
performance in a healthy control sample at both time points (Arbuthnott & Frank, 2000; 
Perianez et al., 2007; David Wechsler, 1997).  Thus, as compared to previously published 
norms and healthy control data, participant performance on cognitive tasks in the current 
study was within a normal range.  
 Many mixed results have been reported with regard to whether individuals with 
AN demonstrate impaired performance on the specific cognitive tests included in the 
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current study.  With regard to memory, some studies have identified deficits in 
performance of AN individuals on the measures of verbal recall, while others have 
reported no verbal recall impairment for AN individuals as compared to HCs (Kingston 
et al., 1996; Lauer et al., 1999; Mathias & Kent, 1998; Nikendei et al., 2011; Steinglass et 
al., 2006).  A study evaluating working memory using letter number sequencing similarly 
reported AN performance was within a normative range, however the same study 
identified deficits with regards to healthy controls matched for education level (Weider, 
Indredavik, Lydersen, & Hestad, 2014).  Previous reports of cognitive flexibility in AN 
have often incorporated the Trail Making Test.  Reports of Trail Making Test 
performance in AN are similarly mixed (Kingston et al., 1996; Nikendei et al., 2011; 
Roberts et al., 2010; Kate Tchanturia et al., 2004), however a meta-analysis identifies a 
small overall effect size for Trails B impairment (Roberts, Tchanturia, Stahl, Southgate, 
& Treasure, 2007).  Findings with regard to block design performance among AN 
individuals are also varied, (Galderisi et al., 2003; Kingston et al., 1996; Lopez et al., 
2008; Mathias & Kent, 1998; Szmukler et al., 1992), while a meta-analysis suggests that 
individuals with AN tend to display poorer block design performance as compared to 
healthy controls (Lopez et al., 2008).  Thus, the lack of definitive cognitive impairment 
seen in the current study is somewhat unexpected; at the same time the finding is 
consistent with some other reports that do not identify cognitive impairments in the 
specific domains tested. 
 Importantly, while no cognitive impairment was identified as compared to 
normative data, it is impossible to know what participant cognitive performance looked 
like prior to the onset of AN.  It is possible that individuals in the current study did not 
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experience a change in cognitive function associated with the disorder; however, it is also 
possible that these individuals had superior cognitive ability prior to the onset of the 
disorder.  In fact, in a recent study of adolescents with AN presenting for the first time for 
the treatment, weight restored individuals with AN performed better than matched 
healthy controls on several cognitive tasks, even though their performance on several 
measures looked similar to the same healthy controls during the acute underweight state 
(Hatch et al., 2010).  It may be that adolescents, with a shorter duration of illness than 
adults, may be more likely to return to their premorbid level of functioning as compared 
to individuals who have been malnourished and battled with AN for an extended period.  
Thus, this finding raises the possibility that some AN individuals may experience 
superior cognitive functioning prior to the onset of AN, such that normal performance 
during the acute stage of the disorder is actually representative of a relative cognitive 
decline.  
 In addition to no identifiable cognitive impairment in the current study, 
participants did not significantly improve between admission and post-weight restoration 
time points.  Although this does not preclude the possibility that weight status has an 
effect on cognitive performance  
(as theoretically one could have not regained enough weight or not maintained a new 
weight for a long enough period of time to allow for a potential effect), it is consistent 
with the interpretation that weight status is not directly related to the specific tasks 
included in the current study.   
 Furthermore, while weight status was not directly related to cognitive 
performance in the current study, it is possible that the relationship between these 
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variables is non-linear or categorical, rather than continuous.  It may be that there is a 
body mass and/or WS threshold such that if an individual goes below that threshold, they 
may exhibit impaired cognitive functioning; however, the degree to which one is below 
that threshold may not further affect cognitive function (categorical relationship), or a 
dose-response-like effect may only be seen in individuals with weights below a particular 
weight status threshold (non-linear relationship).  In fact, a threshold model has been 
proposed by others regarding the effect of leptin signaling on metabolic response, with 
large changes in energy expenditure and food intake typically associated with changes 
below a particular individual’s leptin threshold and minimal changes in energy 
expenditure and food intake typically associated with changes occurring above the 
threshold (Rosenbaum & Leibel, 2014).  Thus, the behavioral response associated with 
leptin status does not appear to be directly proportional to change in leptin.  It is possible 
that cognitive functions have a different weight status threshold than that associated with 
metabolic function, and different domains of cognitive function could theoretically have 
different thresholds from one another.  Furthermore, individuals may vary with regard to 
the level of leptin associated with any potential threshold effect, which would complicate 
the identification of a relationship between weight status and cognitive performance 
variables.    
 A handful of studies have evaluated cognitive performance in individuals with 
AN during both an acute illness and post-weight restoration time point.  Importantly, 
because it is often difficult to obtain a large sample of individuals with AN prior to and 
following weight restoration, sample sizes among studies reporting cognitive changes are 
often small, such that some studies are underpowered.  In these cases, null finding are not 
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particularly meaningful, given that the study may have lacked the appropriate power to 
detect an effect. Although evaluating change in cognitive performance between time 
points was not a specific goal of the current study, the current study was only sufficiently 
powered to detect such differences for cognitive changes with a medium effect size or 
greater; therefore, the current study was not adequately powered to detect change 
associated with smaller effect sizes. 
 With regard to memory, findings from the current study are consistent with 
findings from four other studies that also reported no change in verbal memory 
performance between acute AN and weight restoration through treatment (Green et al., 
1996; Kingston et al., 1996; Lauer et al., 1999; Nikendei et al., 2011). Notably, 
participants in the current study on average restored their weight to a higher absolute 
body weight than individuals in the former studies; in two of the former studies (Green et 
al., 1996; Kingston et al., 1996), participant average post-weight restoration BMI was 
still low enough to be considered medically unhealthy by absolute body weight standards.  
Thus, the current study extends these findings by noting that even with greater weight 
restoration, memory performance did not change in response to treatment. Null findings 
from the current study are contrasted by findings from Moser and colleagues (2002) who 
reported improved verbal memory performance on a memory recall task following 
weight restoration among individuals with AN.   
 With regard to cognitive flexibility, Tchanturia and colleagues (2004) reported no 
change in cognitive flexibility, including Trails Making Task performance, between acute 
AN and following weight restoration; however, a separate group of individuals who had 
recovered from AN (at least one year prior) performed somewhat better than individuals 
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with acute illness, though not quite as well as HCs.  Another study also reported that 
individuals recovered from AN showed somewhat better performance on cognitive 
flexibility tasks than individuals with acute AN (Roberts, 2010).  One interpretation of 
this data is a delayed influence of weight status on cognitive flexibility in AN; however, 
because these studies evaluated between group differences, rather than longitudinal 
within-subject changes in cognitive function, other explanations are possible.  It may be 
that individuals with AN who have better cognitive functioning are the ones to recover 
from the disorder, such that the between-group differences are not representative of a true 
change in functioning (Roberts, 2010).    
 The current study was unable to evaluate change in visuospatial ability due to the 
availability of this data at the post-weight restoration time point only.  In general, the 
literature is inconclusive with regard to changes in visuospatial ability following 
treatment for AN; Kingston et al. (1996) report no improvement following weight 
restoration while Szmukler (1992) reports visuospatial improvement.  Taken together, 
while findings are somewhat mixed, the current finding of no cognitive improvement 
associated with weight restoration in AN in the domains assessed is consistent with many 
previous reports.   
 The lack of relationship between weight status variables and cognitive task 
performance is consistent with some previous studies and inconsistent with others.  
Similar to findings from the current study, Bayless et al. (2002) reported no relationship 
between BMI and either memory or cognitive flexibility (specifically, Trails Making 
Task) performance.  Furthermore, Moser et al. (2002) reported no relationship between 
BMI and either memory or visuospatial construction.  Results from the current study are 
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inconsistent with findings from Kingston et al. (1996) who reported BMI during acute 
AN was associated with both memory and cognitive flexibility domain composite scores 
and additionally identified a relationship between percent of premorbid body weight – a  
relative weight status variable – and memory domain score.  Mathias and colleagues 
(1998) also reported a relationship between BMI and cognitive flexibility, namely Trails 
Making Task performance; however they did not identify a relationship between BMI 
and memory or block design performance.  Notably, while the majority of prior studies 
only considered the relationship between cognitive performance and absolute weight 
status (with the exception of Kingston et al.) the current study extended the consideration 
of weight status to WS.  The finding of no relationship between either BMI or WS and 
cognitive performance in the current study may represent a lack of relationship between 
weight status and cognitive deficits in AN, or may be accounted for by the lack of 
cognitive performance deficits identified in the current study.   
 Given that weight status was not related to cognitive performance in the current 
study, it is not surprising that there was no identified relationship between leptin and 
cognitive task performance.  Leptin has been associated with visuospatial memory task 
performance in rodents, and limited evidence suggests leptin may also be associated with 
some measures of cognitive performance in humans (Li et al., 2002).  To our knowledge, 
the current study was the first study to evaluate the relationship between leptin and 
cognitive performance in individuals with AN. Although there was no statistically 
significant relationship between leptin and cognitive performance, effect sizes were also 
considered given that these analyses were underpowered.  In the majority of domains 
tested, the relationship between leptin and cognitive performance demonstrated a small 
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effect size, suggesting that in most cases, non-significant findings were likely not due to 
low statistical power. In these cases, null findings may be attributable to the lack of 
cognitive deficits identified in the current sample, and may also suggest that these 
measures are not influenced by leptin status.   
 In the case of block design post-weight restoration, although the positive 
association between task performance and leptin did not achieve statistical significance, it 
did reach a medium effect size.  Thus, small sample size may have influenced the ability 
to detect a relationship between block design and leptin.  If a relationship between block 
design and leptin were established, this could suggest that leptin is not only associated 
with visuospatial ability in rodents, but also in a human population.  For individuals with 
AN, this could mean that some aspects of visuospatial performance are related to leptin 
status, such that individuals with lower leptin levels perform more poorly on such tasks. 
Furthermore, the effect size for the relationship between visuospatial ability and weight 
status fell between small and medium, such that the lack of identified relationship 
between these variables could also be influenced by sample size.   
Importantly, because visuospatial deficits were not observed in the current sample, 
interpretation of a relationship with either weight status or leptin variables may be 
inappropriate.  Further research is needed to determine the extent to which visuospatial 
performance and leptin level are related in individuals with AN. 
 Strengths of this study include a novel approach to understanding the relationship 
between weight status and cognitive performance in AN, including the integration of 
physiological and neuropsychological assessment. The inclusion of measurements of 
weight status and cognitive function at both admission and post-restoration time points 
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also represents a study strength.  Relatedly, many eating disorder treatment facilities are 
not able to provide the extended duration of treatment received by individuals included in 
the current study.  Participants in the current study received treatment through 
achievement of a at least 90% Ideal Body Weight; the achievement of a medically 
healthy body weight (by absolute standards) as of the second time point serves as a study 
strength, provided that weight-related variables were central to the study questions.  
 The current study has several limitations that impact the interpretation of findings.  
First, the lack of an identification of cognitive deficits in the domains tested limited the 
ability to test for any relationship between cognitive deficits and weight-related variables.  
The identification of such deficits was an assumed prerequisite to the testing of specific 
factors that may be associated with such deficits; therefore it is difficult to interpret null 
results.  Additionally, because this study was based on data collected for the purposes of 
two other protocols, the cognitive measures included were not specifically selected for 
the current set of research questions and instead were based on what data was available.  
Relatedly, because data was collected for the purposes of two different protocols, the 
collection of neuropsychological measures and leptin did not occur on the same day. 
Leptin fluctuates over the course of a day (Stoving et al., 1998), and, in healthy women, 
has been shown to fluctuate throughout the course of a week or month (Ludwig, Klein, 
Diedrich, & Ortmann, 2000); thus if a relationship between cognitive function and leptin 
did exist, testing on different days, or even at different times of day, may make this 
relationship harder to detect.  The small sample size for individuals with leptin data 
available is also a limitation, given that analyses involving leptin were all underpowered.  
Additionally, while the purpose of this study was not to compare cognitive performance 
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between AN individuals and healthy controls, lack of a control group limited our 
interpretation of cognitive performance to comparisons with normed data.   
 In light of the identified relationship between WS and leptin, future studies should 
evaluate whether leptin levels at discharge relate to eating disorder psychopathology, as 
well as longer-term eating disorder recovery.  Provided the predictive utility of WS in 
eating disorder psychopathology, depression, and long-term weight status (S. Berkowitz 
et al., 2011, April; S. A. Berkowitz et al., 2012, November; Berner et al., 2013; Klein et 
al., 2011, July; Wildes & Marcus, 2012; Witt et al., 2014), the next step would be to 
determine whether leptin can also meaningfully predict such outcomes.   Additionally, 
future studies should continue to evaluate the relationship between weight status and 
cognitive performance in AN using a new set of cognitive measures before ruling out this 
potential relationship.  In the future, evaluation of the relationship between weight-status 
and cognitive impairment would benefit from cognitive measures specifically selected for 
this purpose.  The inclusion of cognitive measure more consistently associated with 
deficits in AN individuals or the inclusion of measures more closely associated with 
leptin would allow for a more rigorous study design.  Given that leptin has been 
demonstrated to have a causal impact on visuospatial memory in rodents, a task that 
specifically evaluates this domain (rather than the independent domains of verbal 
memory and visuospatial ability as measured in the current study) may provide more 
meaningful data.  Therefore, tasks such as the Rey-Osterrieth Complex Figure Test 
(Meyers & Meyers, 1996), a cognitive task measuring visuospatial memory, or the 
Wisconsin Card Sorting Test (Heaton, 1993), a set-shifting task more consistently 
associated with deficits among AN individuals, may be appropriate measures to consider. 
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Furthermore, a larger sample size and collection of leptin data on the same day as 
cognitive testing would improve upon reports from the current study. It would also be 
interested to conduct a similar study with adolescents with AN with a shorter duration of 
illness.  It is possible that some of the cognitive impairments seen in adults with AN are 
more representative of a “scar” of brain malnourishment during critical developmental 
periods, or general chronicity associated with sustained mental illness (Hatch et al., 
2010); an adolescent sample would allow some of these constructs to be evaluated 
without complications associated with long-term illness.  Although the current study 
findings are inconclusive with regard to whether there might be an association between 
weight status and cognitive impairment in AN, a larger study that addresses the current 
study limitations would be interesting whether findings were null or significant; either 
way, they would help tease apart the potential for cognitive impairment in AN to be 
related to weight status as compared to variables more intrinsic to the psychopathology 
associated with the disorder.  
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Table 1. Descriptive Statistics and Paired Sample Mean Comparisons 
 Admission Following weight 
restoration 
Mean Comparisons 
Characteristic N M SD N M SD t df p 
Age (years) 64 24.53 6.94 - - - - - - 
Years of education 64 13.98 2.06 - - - - - - 
Duration of illness 
(years) 
64 8.26 6.71 - - - - - - 
Body Mass Index 
(kg/m2)  
64 16.63 1.56 49 20.23 .59 -19.17 48 <.01** 
Weight suppression 
(lbs) 
63 37.15 22.55 47 18.85 24.62 17.67 46 <.01** 
Leptin (ng/mL) 29 1.48 1.63 22 5.27 3.92 -5.87 17 <.01** 
EDE global score 60 3.24 1.36 52 2.56 1.26 3.89 48 <.01** 
CVLT: Immediate 
Recall (T-score) 
59 53.25 8.58 45 51.49 10.29 .79 43 .44 
CVLT: Short Delay 
Free Recall (standard 
score) 
59 .26 .81 45 .12 1.02 .83 43 .41 
CVLT: Short Delay 
Cued Recall  (standard 
score) 
59 -.09 .88 45 .31 .82 -2.20 43 .03* 
CVLT: Long Delay 
Free Recall (standard 
score) 
59 .08 .89 45 -.07 .93 1.20 43 .24 
CVLT: Long Delay 
Cued Recall (standard 
score) 
59 .01 .89 45 .17 .79 -1.03 43 .31 
CVLT: Learning 
Slope Trials 1-5 
(standard score) 
59 .08 .89 45 .29 1.00 -1.28 43 .21 
Trails B –A 
Difference Score 
61 30.69 12.44 47 29.14 12.44 1.12 43 .27 
Letter Number 
Sequencing 
63 11.13 2.05 48 11.96 2.75 -1.69 46 .10 
Block Design T-score - - - 51 51.53 10.27 - - - 
WTAR FSIQ 60 107.45 8.56 - - - - - - 
Note. Means are listed based on the full sample of participants, while t-test are completed 
based on data available at both time points.  * Statistically significant at p < .05.  ** 
Statistically significant at p < .01. 
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Table 2. Pearson Correlations Among Admission Variables  
  1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 
1 Age (years) - - - - - - - - - - - - - - - - 
2 Years of education .43** - - - - - - - - - - - - - - - 
3 Duration of illness 
(years) 
.81** .36** - - - - - - - - - - - - - - 
4 Body Mass Index 
(kg/m2)  
-.21 -.13 -.21 - - - - - - - - - - - - - 
5 Weight suppression 
(lbs) 
.19 .05 .04 .12 - - - - - - - - - - - - 
6 Leptin (ng/mL) -.21 .01 -.02 .16 -.26 - - - - - - - - - - - 
7 EDE global score .09 .09 .23 .27* .19 .32 - - - - - - - - - - 
8 CVLT: Immediate 
Recall  
-.37** -.13 -.37** .06 -.03 .13 -.06 - - - - - - - - - 
9 CVLT: Short Delay 
Free Recall  
-.29* -.03 -.21 .13 -.12 .14 -.05 .69** - - - - - - - - 
10 CVLT: Short Delay 
Cued Recall   
-.16 .09 -.12 .01 -.29* -.03 -.10 .53** .58** - - - - - - - 
11 CVLT: Long Delay 
Free Recall  
-.25 .05 -.24 .12 -.07 .06 -.13 .70** .75** .58** - - - - - - 
12 CVLT: Long Delay 
Cued Recall  
-.25 .00 -.17 .14 -.15 .09 -.04 .62** .77** .69** .84** - - - - - 
13 CVLT: Learning 
Slope Trials 1-5 
-.06 .11 -.04 .17 -.03 -.08 -.11 .05 .43** .10 .25 .14 - - - - 
14 Trails B –A 
Difference Score 
-.10 -.02 -.02 -.01 .01 -.22 -.09 .00 .01 .09 -.01 .11 .16 - - - 
15 Letter Number 
Sequencing 
.18 .41** .00 .02 .09 -.10 .19 .16 .04 .12 .12 .01 -.02 -.27 - - 
16 WTAR FSIQ .23 .55** .13 .03 -.01 .03 -.06 .19 .01 .02 .154 .01 -.04 -.14 .36** - 
Note. *Statistically significant at p < .05.  **.Statistically significant at p < .01. 
!! "#!
Table 3. Pearson Correlations Among Post-Weight Restoration Variables 
  1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 
1 Age (years) - - - - - - - - - - - - - - - - - 
2 Years of education .43** - - - - - - - - - - - - - - - - 
3 Duration of illness 
(years) 
.81** .36** - - - - - - - - - - - - - - - 
4 Body Mass Index 
(kg/m2)  
.29* .10 .27 - - - - - - - - - - - - - - 
5 Weight suppression 
(lbs) 
.01 -.04 -.13 .29 - - - - - - - - - - - - - 
6 Leptin (ng/mL) -.28 -.14 -.23 -.10 -.43** - - - - - - - - - - - - 
7 EDE global score .10 .13 .12 .11 .19 .14 - - - - - - - - - - - 
8 CVLT: Immediate 
Recall  
-.43** -.24 -.42** -.12 .14 .17 -.20 - - - - - - - - - - 
9 CVLT: Short Delay 
Free Recall  
-.34* -.13 -.35* -.03 .18 .06 -.14 .89** - - - - - - - - - 
10 CVLT: Short Delay 
Cued Recall   
-.19 -.03 -.22 -.02 .04 .15 .00 .79** .85** - - - - - - - - 
11 CVLT: Long Delay 
Free Recall  
-.41** -.22 -.43** -.06 .04 -.02 -.16 .79** .82** .76** - - - - - - - 
12 CVLT: Long Delay 
Cued Recall  
-.27 -.18 -.28 .01 -.12 .14 -.06 .68** .78** .79** .79** - - - - - - 
13 CVLT: Learning 
Slope Trials 1-5 
-.22 .07 -.21 -.11 .01 .01 .08 .12 .25 .24 .16 .26 - - - - - 
14 Trails B –A 
Difference Score 
.07 -.03 .08 .15 -.01 -.33 .05 .03 -.02 .15 .09 .09 .04 - - - - 
15 Letter Number 
Sequencing 
.08 .25 -.01 .14 -.19 .14 -.16 .02 -.02 .05 .12 .10 .06 .03 - - - 
16 WTAR FSIQ .23 .55** .13 .04 .02 -.13 .12 .09 .16 .23 .10 .12 -.13 -.05 .41** - - 
17 Block Design -.02 .01 .03 -.32* .-.21 .39 -.05 .08 .15 .07 .10 -.02 .04 -.23 .08 -.03 - 
Note. *Statistically significant at p < .05.  **.Statistically significant at p < .01. 
!! "$!
Table 4. Independent Samples Mean Comparisons between Anorexia Nervosa Subtypes  
 Admission Post-Weight Restoration 
 AN-R AN-BP  AN-R AN-BP  
Characteristic M SD M SD t df p M SD M SD t df p 
Body Mass Index 
(kg/m2)  
16.25 1.46 16.98 1.58 -1.93 62 .06 20.02 .42 20.43 .66 -2.55 47 .01* 
Weight suppression (lbs) 32.88 19.37 41.05 24.74 -1.45 61 .15 14.30 20.00 23.20 28.10 -1.25 45 .22 
Leptin (ng/mL) 1.72 1.78 .93 1.15 1.21 27 .24 5.67 4.55 4.22 .79 1.22 17.18 .24 
CVLT: Immediate 
Recall (T-score) 
54.04 9.19 52.55 8.08 .66 57 .51 55.17 9.02 47.64 10.30 2.62 43 .01* 
CVLT: Short Delay Free 
Recall (standard score) 
.39 .69 .15 .89 1.18 57 .24 .39 .95 -.16 1.04 1.85 43 .07 
CVLT: Short Delay 
Cued Recall  (standard 
score) 
.16 .78 -.32 .91 2.18 57 .03* .52 .79 .09 .81 1.81 43 .08 
CVLT: Long Delay Free 
Recall (standard score) 
.29 .71 -.10 1.00 1.67 57 .10 .15 .95 -.30 .88 1.64 43 .11 
CVLT: Long Delay 
Cued Recall (standard 
score) 
.27 .62 -.23 .86 2.50 57 .02* .35 .66 -.02 .88 1.60 43 .12 
CVLT: Learning Slope 
Trials 1-5 (standard 
score) 
-.13 .98 .18 1.14 -1.09 57 .28 .22 1.06 .36 .95 -.49 43 .63 
Trails B –A Difference 
Score 
29.80 14.36 31.60 10.26 -.56 59 .58 26.37 12.96 31.79 11.56 -1.51 45 .14 
Letter Number 
Sequencing 
11.03 1.58 11.22 2.45 -.36 53.26 .72 12.04 2.60 11.88 2.95 .21 46 .84 
Block Design T-score - - - - - - - 52.96 7.88 50.04 12.26 1.02 49 .32 
Note. * Statistically significant at p < .05.  ** Statistically significant at p < .01.
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Table 5. Independent and Interactive Predictive Effects of Weight Suppression and Body 
Mass Index at Admission 
 BMI WS WS x BMI R2 
 B (SE) p B (SE) p B (SE) p  
Leptin at admission .69(.26) <.01** -.02(.01) .03** -.02(.02) .89 .41 
 CVLT: Immediate 
Recall 
 
.38(.76) .63 -.02(.05) .74 .03(.05) .84 .01 
CVLT: Short Delay 
Free Recall  
 
.08(.07) .30 -.01(.01) .18 .002(.004) .65 .05 
CVLT: Short Delay 
Cued Recall   
 
.02(.07) .81 -.01(.01) .02** .000(.004) .99 .09 
CVLT: Long Delay 
Free Recall  
 
.11(.06) .08 -.01(.00) .16 .00(.00) .64 .08 
CVLT: Long Delay 
Cued Recall  
 
.09(.07) .24 -.01(.01) .17 .00(.00) .90 .05 
CVLT: Learning Slope 
Trials 1-5 
 
.12(.09) .20 .00(.01) .77 .01(.01) .51 .03 
Trails B –A Difference 
Score 
 
-.06(1.05) .97 .01(.07) .92 .09(.07) .15 .00 
Letter Number 
Sequencing 
.01(.17) .91 .01(.01) .24 .00(.01) .73 .02 
Note. BMI = body mass index; WS = weight suppression. For ease of interpretation, B and 
standard error of B values are reported in original units of the outcome variable rather than in 
transformed units. In cases of non-significant interactions, the main effect data shown are from 
models that were re-run without the interaction term. Due to impact of outliers on central 
tendency, analyses are reported with outliers removed; statistical significance was unchanged 
when analyses were completed with outliers. *Statistically significant at p < .05.  **.Statistically 
significant at p < .01. 
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Table 6. Independent and Interactive Predictive Effects of Weight Suppression and BMI 
Post-Weight Restoration 
 BMI WS WS x BMI R2 
 B (SE) p B (SE) p B (SE) p  
Leptin post-weight 
restoration 
 
1.53(2.12) .48 -.11(.05) .03** .13(.15) .39 .24 
 CVLT: Immediate 
Recall 
 
-2.66(3.51) .47 .08(.07) .19 .10(.09) .20 .05 
CVLT: Short Delay 
Free Recall  
 
-.15(.35) .66 .01(.01) .11 .01(.01) .19 .07 
CVLT: Short Delay 
Cued Recall   
 
.05(.28) .94 .00(.01) .47 .00(.01) .72 .02 
CVLT: Long Delay 
Free Recall  
 
-.12(.26) .52 .00(.01) .29 .01(.01) .52 .03 
CVLT: Long Delay 
Cued Recall  
 
.00(.27) .84 .00(.01) .83 .01(.01) .62 .00 
CVLT: Learning Slope 
Trials 1-5 
 
-.38(.36) .24 .00(.01) .39 .00(.01) .93 .05 
Trails B –A Difference 
Score 
 
3.10(3.37) .41 -.03(.08) .99 .02(.11) .80 .02 
Letter Number 
Sequencing 
 
-.02(.83) .79 -.03(.02) .42 -.01(.02) .36 .02 
Block Design -3.77(3.02) .20 -.06(.06) .31 -.02(.08) .67 .08 
Note. BMI = body mass index; WS = weight suppression. For ease of interpretation, B and 
standard error of B values are reported in original units of the outcome variable rather than in 
transformed units. In cases of non-significant interactions, the main effect data shown are from 
models that were re-run without the interaction term. Due to impact of outliers on central 
tendency, analyses are reported with outliers removed; statistical significance was unchanged 
when analyses were completed with outliers. *Statistically significant at p < .05.  **.Statistically 
significant at p < .01. 
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Table 7. Predictive Effect of Leptin on Cognitive Task Performance at Admission 
 Leptin R2 
 B (SE) p  
 CVLT: Immediate Recall .61(.93)   .89  .03 
CVLT: Short Delay Free Recall  .07(.09)   .98  .00 
CVLT: Short Delay Cued Recall   -.02(.11) .45 .02 
CVLT: Long Delay Free Recall  .02(.08) .77 .00 
CVLT: Long Delay Cued Recall  .04(.07) .90 .00 
CVLT: Learning Slope Trials 1-5 -.06(.14) .63 .01 
Trails B –A Difference Score -1.88(1.61) .63 .01 
Letter Number Sequencing -.14(.26) .33 .04 
Note. For ease of interpretation, B and standard error of B values are reported in original units 
of the outcome variable rather than in transformed units. Due to impact of outliers on central 
tendency, analyses are reported with outliers removed; statistical significance was unchanged 
when analyses were completed with outliers. *Statistically significant at p < .05.  **.Statistically 
significant at p < .01. 
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 Table 8. Predictive Effect of Leptin on Cognitive Task Performance Post-Weight Restoration 
 Leptin R2 
 B (SE) p  
 CVLT: Immediate Recall .41(.45) .47   .03 
CVLT: Short Delay Free Recall  .01(.06)   .81   .00 
CVLT: Short Delay Cued Recall   .03(.05) .53 .02 
CVLT: Long Delay Free Recall  .00(.05) .94 .00 
CVLT: Long Delay Cued Recall  .03(.04) .55 .02 
CVLT: Learning Slope Trials 1-5 .00(.06) .98 .00 
Trails B –A Difference Score -1.04(.71) .16 .10 
Letter Number Sequencing .11(.18) .48 .03 
Block Design 1.08(.58) .07 .15 
Note. For ease of interpretation, B and standard error of B values are reported in original units 
of the outcome variable rather than in transformed units. Due to impact of outliers on central 
tendency, analyses are reported with outliers removed; statistical significance was unchanged 
when analyses were completed with outliers. *Statistically significant at p < .05.  **.Statistically 
significant at p < .01.  
df)(Lowe et al., 2006) 1Stice, Durant, Bu 
 
Lowe, M., Annunziato, R., Markowitz, J., Didie, E., Bellace, D., Riddell, L., . . . Stice, E. 
(2006). Multiple types of dieting prospectively predict weight gain during the 
freshman year of college. Appetite, 47(1), 83-90.  
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Figure 1. Body mass index (BMI) and weight suppression in the prediction of leptin at admission  
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Figure 2. Body mass index (BMI) and weight suppression in the prediction of leptin post-weight restoration  
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Appendix: Summary of Weight Suppression Findings in Bulimia and Anorexia Nervosa  
Table A1 
Weight Suppression Findings in Bulimia Nervosa 
Paper Sample  Design Covariates Outcome variables Findings 
Weight Change  
Lowe, Davis, 
Lucks, 
Annunziato, & 
Butryn, 2006 
 
146 
inpatients 
Longitudinal: admission; 
discharge 
• BMI 
• Previous highest BMI 
• Length of stay 
• Current dieting 
• Purging frequency 
• Weight gain 
 
Higher WS and lower BMI at 
admission independently predicted 
weight gain during hospitalization 
Herzog, Thomas, 
Kass, Eddy, 
Franko, & Lowe, 
2010 
97 
treatment-
seekers  
Longitudinal, naturalistic: 
baseline; 5-year follow up 
• BMI 
• Age 
• Weight gain Higher WS was associated with 
greater weight gain over 5-year 
follow-up 
Carter, McIntosh, 
Joyce, & Bulik, 
2008 
132 
outpatients  
Longitudinal: pre-treatment; 
post-treatment 
(None) • Weight gain 
• Treatment (CBT) 
completion  
• Abstinence from 
binge 
eating/purging 
• Binge/purge 
frequency 
Higher WS at admission predicted 
greater weight gain over treatment; 
WS did not predict drop out from 
treatment or binge/purging 
Symptom Change 
Butryn, Lowe, 
Safer, & Agras, 
2006  
 
188 
outpatients  
Longitudinal: pre-treatment; 
post-treatment 
• BMI 
• Duration of binge eating 
• Three-Factor Eating 
Questionnaire – Restraint 
• EDE subscales (restraint, 
weight, shape, eating) 
• Additional EDE 
measures (objective 
binge eating, purging  
• Treatment (CBT) 
completion  
• Abstinence from 
binge 
eating/purging 
Higher WS was associated with 
greater drop out from treatment 
and, among treatment completers, 
higher rates of continued binge 
eating/purging following treatment   
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episodes)  
• highest past weight 
• difference between 
current weight and 
lowest weight 
Butryn, 
Juarascio, & 
Lowe, 2011 
64 
outpatients  
Crossectional: pre-treatment • BMI   
• Length of illness 
• Age  
• EDE subscales (restraint, 
eating, weight, shape) 
• Binge eating 
frequency  
• Purging frequency 
There was an interaction between 
WS and BMI on binge eating 
frequency – higher WS and lower 
BMI were associated with greater 
binge eating; higher WS was 
associated with greater purging 
frequency 
Lowe, Safer, & 
Butryn, 2007 
194 
outpatients  
Crossectional: pre-treatment • EDE restraint subscale • Binge eating 
frequency 
Higher WS was associated with 
greater frequency of binge eating 
Zunker, Crosby, 
Mitchell, 
Wonderlich, 
Peterson, & 
Crow, 2011 
128 
outpatients 
Longitudinal: pre-treatment; 
post-treatment 
(None) • Treatment (CBT) 
completion  
• Abstinence from 
binge 
eating/purging 
• Binge/purge 
frequency reduction 
• Weight change 
WS did not significantly predict 
treatment completion, binge 
eating/purging, weight change 
Lowe, Berner, 
Swanson, Clark, 
Eddy, Franko, 
Shaw, & Ross, 
2011 
110 
treatment-
seekers 
Longitudinal, naturalistic: 
baseline; every 6-12 months 
for 8 years 
• Baseline weight 
• Highest past weight 
• Age 
• difference between 
current weight and 
lowest weight 
• weight change over 
follow-up 
• Time to first full 
remission from BN 
Higher WS was associated with 
longer time to remission from BN  
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Table A2 
Weight Suppression Findings in Anorexia Nervosa 
Paper Sample size Design Covariates Outcome variables Findings 
Weight and Symptom Change   
Wildes & 
Marcus, 2012 
185 
day/inpatients 
Longitudinal: admission; 
discharge 
• BMI 
• Days in treatment 
• Patient status (day 
patient; inpatient) 
• AN subtype 
• Number of prior 
hospitalizations 
• Weight gain 
• Rate of weight gain 
• Binge 
eating/purging 
Higher WS at admission was 
associated with greater and faster 
weight gain during treatment and 
increased likelihood of binge 
eating/purging at discharge  
Berner, Shaw, 
Witt, Lowe, 2013 
337 inpatients Crossectional: admission 
 
Longitudinal: admission; 
discharge 
• BMI  
• Age 
Additional longitudinal: 
• Weight change during 
treatment 
• Admission 
symptomatology scores  
• Eating disorder and 
depressive 
symptomatology at 
(1) admission and 
(2) discharge 
• BMI @ discharge 
Higher WS associated with more 
severe eating disorder and 
depressive symptomatology at 
admission; WSxBMI at admission 
predicted symptomatology and 
BMI at discharge 
Witt, Berkowitz, 
Gillberg, Lowe, 
Rastam, & 
Wentz, 2014 
51 
adolescents  
Longitudinal, naturalistic: 
initial AN episode and 6, 10, 
and 18-year follow-up   
 
• BMI  
• Age  
• BMI at follow-up 
• Duration of AN 
• Duration of eating 
disorder 
WSxBMI predicted BMI at follow-
up; WS and WSxBMI did not 
predict duration of AN or eating 
disorder duration 
 
Klein, Siegel, 
Grunebaum,  
Wang, Chen, & 
Walsh, 2011, 
July 
44 inpatients Crossectional: following 
weight restoration 
(None) • Leptin  
• Resumption of 
menses  
WS was positively associated with 
leptin level; individuals who 
resumed menses showed lower WS 
levels  
Berkowitz, 
Roberto, Sysko, 
Mayer, & Attia, 
2011, April 
57 inpatients Crossectional: discharge 
following weight restoration 
• BMI 
• Time since last 
menstrual period at 
admission 
• Discharge BMI 
• Resumption of 
menses  
Higher WS at discharge was 
associated with decreased 
likelihood of resumption of menses 
prior to discharge 
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